Boise State University

ScholarWorks
Doctor of Nursing Practice Projects

School of Nursing

Spring 2022

A Chronic Obstructive Pulmonary Disease Pilot Using Risk
Stratification to Improve Resource Allocation and Reduce
Readmissions
Linda Gould
Boise State University

1

A Chronic Obstructive Pulmonary Disease Pilot Using Risk Stratification to Improve
Resource Allocation and Reduce Readmissions

A Scholarly Project Presented to the Faculty of the School of Nursing
Boise State University

In partial fulfillment of the requirements
For the Degree of Doctor of Nursing Practice

By
Linda Gould

Committee Chair: Pamela Gehrke, EdD, RN, DNP in Leadership Program Director
Committee Member: Ron Ordona, DNP, FNP-BC, GS-C

2

Table of Contents
Abstract ……………………………………………………………..……………….……………6
Introduction ………………………………………………………...……………………………..7
Problem Background ………………………………………………………………..……7
Local Problem ………………………………………………...…………………………..9
Available Knowledge …………………………………………………...……………….………..9
Literature Review ……………………………………………..………………………….9
Synthesis of the Evidence ……………………………………….………………………10
Rationale ………………………………………………………………………………………...11
Theoretical Model ……………………………………………………………………….11
Project Framework ………………………………………………………………………12
Specific Aims ……………………………………………………………………...…………….12
Methods ………………………………………………………………………………………….13
Contextual Elements for the Project Intervention ……………………………………….13
Population ……………………………………………………………………….13
Settings and Resources ………………………………………………………….14
Congruence of the Project with the Healthcare Facility Readiness for Change ...14
Strengths and Weaknesses ………………………………………………………14
Memorandum of Understanding ………………………………………………...15
Interventions …………………………………………………………………………….15
Correlation of Interventions with the Theoretical Model ……………………….15
Correlation of Interventions with the Project Framework ………………………16

3

Description of the Intervention ………………………………………………………….17
Measures ………………………………………………………………………………...18
Data Analysis ……………………………………………………………………………20
Ethical Considerations …………………………………………………………………………..21
Ethical Considerations and Protection of Participants …………………………………..21
Conflicts of Interest ……………………………………………………………………...22
Biases ……………………………………………………………………………………22
Threats to Quality ……………………………………………………………………….23
Internal Review Board and Project Determination ………………..………………….…23
Results …………………………………………………………………………………….……..24
Timeline …………………………………………………………………………………24
Steps of Interventions …………………………………………………………………...24
Process Measures and Outcomes ………………………………………………………..25
Missing Data …………………………………………………………………………….28
Unexpected Findings ……………………………………………………………………29
Unintended Consequences ………………………………………………………………30
Project Budget …………………………………………………………………………...30
Discussion ……………………………………………………………………………………….31
Summary of Key Findings ………………………………………………………………31
Interpretation …………………………………………………………………………….31
Association Between Interventions and Outcomes ………….…………………..31
Impact of Project on People and Systems ……………………………….………32
Contextual Elements Influencing the Logic Model ……………………………..32

4

Reasons for Differences Between Anticipated and Observed Outcomes ……….34
Costs and Strategic Trade-offs …………………………………………………..34
Limitations ………………………………………………………………………………35
Conclusions ……………………………………………………………………………………...35
Usefulness of the Work ………………………………………………………………….35
Sustainability …………………………………………………………………………….36
Potential for Spread ………………….…………………………………………………..37
Future Study ……………………………………………………………………..37
Implications for Policy and Practice Development …………………………………..…38
Next Steps ……………………………………………………………………………….41
References ……………………………………………………………………………………….43
Appendices ………………………………………………………………………………………55
A. Literature Review Summary ………………………………………………….9 and 55
B. Johns Hopkins Evidence-Based Practice Synthesis and Evidence Tool ……...9 and 93
C. PEARL Risk Stratification Tool (Echevarria et al., 2017) …………………..10 and 98
D. Stetler Theoretical Model ………………………...………………………….11 and 99
E. Logic Model ……………………………………………………………......12 and 100
F. Risk Factors and Social Determinants of Health …………………...……...13 and 107
G. Memorandum of Understanding ………………………………...…………15 and 109
H. COPD Template ……………………………………………………………16 and 111
I. Appropriateness for Inclusion and Exclusion ……………………………...17 and 122
J. Participant Letter …………………………………………………………...17 and 123
K. Transitional Care Management and Primary Care Provider Letter ………..18 and 125

5

L. Outcome Measures …………………………………………………………18 and 127
M. Data Collection Spreadsheet ……………………………………………….18 and 133
N. CITI Certification …………………………………………………………..22 and 134
O. Internal Review Board Letter of Determination …………………………...24 and 136
P. Timeline ……………………………………………………………………24 and 137
Q. Resource Allocation Table …………………………………………………28 and 139
R. Expense Report Year 1 ……………………………………………………..30 and 141
S. Expense Report Year 2-3 Budget …………………………………………..30 and 142
T. Statement of Operations ……………………………………………………30 and 143

6

Abstract
Background: Chronic Obstructive Pulmonary Disease (COPD) impacts 250 million people, is
associated with high hospital readmission rates, and costs over $50 billion annually. Purpose:
Apply risk stratification identifying higher risk patients to prioritize complex, time-consuming
interventions and resources. Methods: Patients hospitalized with COPD were risk stratified using
PEARL. Moderate-high risk patients were referred to specialty nurse practitioners, who used
real-time interventions and motivational interviewing during intense weekly visits over 30 days
targeting self-management, patient-specific risks, and resources. Results: No patients were
readmitted or died during the pilot using risk stratification with patient-specific tertiary
preventive care to communicate resource allocation. Impact: This process provided
recommendations for expansion throughout the healthcare facility, other chronic health
conditions, budgets and policy for value-based care, and further research.
Key words: COPD, risk stratification, transitional care, motivational interviewing, resource
allocation
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A Chronic Obstructive Pulmonary Disease Pilot Using Risk Stratification to Improve
Resource Allocation and Reduce Readmissions
Adult patients with Chronic Obstructive Pulmonary Disease (COPD) have multiple,
complex, and lifelong risk factors that contribute to significant symptoms and higher rates of
hospital readmissions. Additionally, risk factors associated with readmissions are different for
every patient and preventive care interventions may be unknown, not available, or not a priority
for the patient to modify in their specific environment. Hence, it is challenging for healthcare
facilities and providers to understand confidently how to focus care. This scholarly project
(hereafter referred to as project) describes a quality improvement (QI) pilot for patients with
COPD. The project implemented risk stratification during hospitalization and transitional care
for moderate and high-risk patients to expedite referral to an outpatient pulmonary clinic.
Interventions included intense visits to optimize Global Initiative for Chronic Obstructive Lung
Disease (GOLD, 2020) guideline-based therapy (GBT), target self-management, patient-specific
risk factors, and barriers to care (hereafter referred to as patient-specific variables), and
communicating necessary resources for improved patient outcomes.
Problem Background
Chronic obstructive pulmonary disease is a component of chronic lower respiratory
diseases including emphysema and chronic bronchitis. It affects 250 million people worldwide
and contributes to the 3rd leading cause of death globally, nationally, and locally (Heron, 2019;
Idaho Department of Health and Welfare [IDHW], 2018; World Health Organization [WHO],
2019). Patients experiencing acute exacerbation COPD (AECOPD) suffer significant increase in
symptoms of breathlessness, cough, wheezing, and chest tightness beyond normal day to day
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variations thus requiring increased use of rescue medication, acute healthcare visits, and/or
hospital admissions (GOLD, 2020).
The costs of COPD are near $50 billion annually in the U.S., exacerbations contribute to
70% of costs, and the highest prevalence is in the aging population (Centers for Disease Control
and Preventions [CDC], 2020; Fuhrman et al., 2017; Press et al., 2018). The national COPD
readmission rate is high at 19.5% (Medicare, 2019). Hospitals face risks of negative cultural and
financial penalties up to 3% of reimbursements for readmissions within 30 days (Centers for
Medicare and Medicaid Services, Hospital Readmissions Reduction Program [CMS, HRRP],
2012). Over 25% of COPD readmissions are due to AECOPD and over 50% are related to other
conditions (Jencks et al., 2009; Shah et al., 2016). These patients have high co-morbidities as
80% reported at least one comorbidity, great than 60% reported two, and nearly 50% reported
three or more (Dal Negro et al., 2015). Top comorbidities include heart failure, cardiac disease,
respiratory infections, malignancy, diabetes, liver or renal disease, psychiatric problems,
gastrointestinal ailments, and sleep apnea (Dal Negro et al., 2015; Jacobs et al., 2018; Jencks et
al., 2009). Aging and multiple chronic conditions lead to frailty which is 58% higher in patients
with COPD and frail patients have a higher rate of admissions and death (Park et al., 2013).
It is important to identify patients who are the top percent users of healthcare resources
and how to support these patients to avoid hospitalization (Mitchell, 2019). High risk users
consume 1-5% of resources due to multiple, complex chronic conditions, comorbidities, and
hospitalizations, and an additional 30% of patients are moving towards high-risk use (Robert
Woods Johnson Foundation [RWJF], 2017). Risk stratification helps identify and predict patients
at highest risk for resource utilization to help prioritize patient-specific, highly complex, timeconsuming interventions (Crane et al., 2010; Press et al., 2018; Scalable Health, 2018).
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Identifying and managing high risk populations to track improvement in outcomes demonstrates
value to payers known as value-based care (National Council Organization, 2017).
Local Problem
Locally, patients hospitalized for AECOPD are not risk stratified for readmission;
therefore, it is unknown which patients require intensive evaluation and interventions for
resource allocation. The local healthcare facility COPD readmission rate is high at 19% which is
no different from the nation or other state acute care facilities (Medicare.gov, 2019). Age
influences COPD incidence and those in the state under age 45 have 2.2% compared to those
over age 75 having 12.7% (CDC, 2011; Community Health Rankings [CHR], 2020). Projections
for the increased diagnosis of COPD and the state’s rapid growth of retirement population will
increase the disease burden, cost, and need for access to care (Dal Negro et al., 2015; U.S.
Census Bureau, 2018).
Available Knowledge
Literature Review
The following electronic databases were used for the literature search for peer reviewed
studies between 2014-2019 of English language: Academic Search Premier, CINAHL, Medline,
Business Source, Cochrane Library, ERIC, Nexus Uni, PsycINFO, and Google Scholar. Search
terms targeted COPD, hospital readmission, risk stratification, and outcomes. Hand searches for
pertinent articles were completed. Titles were screened and excluded if unrelated to the topic.
The articles were relevant to the problem and provided evidence for the project shown in the
Literature Review Summary table (Appendix A). These were critically appraised using Johns
Hopkins Evidence-Based Practice Synthesis and Evidence Tool (Dang & Dearholt, 2018;
Appendix B).
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Synthesis of the Evidence
Studies yield good to high level evidence from research and field experts reporting no
single but rather variable and complex interventions deployed to reduce readmissions. Timely
evidence-based practice (EBP) is imperative to improve outcomes. Recommendations include
access to quality care to confirm obstruction on spirometry for appropriate guideline-based
therapy, risk stratification, and identify patient-specific variables to strategically allocate
resources in the outpatient community settings (Benzo et al., 2016; Bourbeau & Echevarria,
2019; Kalhan & Mutharason, 2018; Press et al., 2018; Zikos, et al., 2019).
Access to Care
Care team communication at the time of hospital discharge with transitional care
management (TCM) for intense follow-up (generally home visits within 3-7 days and weekly
visits thereafter in the first 30 days) engaging specialty registered and advanced care nurses,
respiratory therapists, and pulmonologists coordinating with the primary care providers (PCP)
(Benzo et al., 2016; Deniger et al., 2015; Naylor et al., 2004; Verhaegh et al., 2014). One study
reported the highest rate of readmission within the first 72 hours of discharge and >50% within
the first 15 days (Jacobs et al., 2018). Another study reported 26% of patients were readmitted
within 30 days but expanded focus is recommended as 74% had an avoidable readmission after
30 days (Krishnan et al., 2015).
Risk Stratification
Risk stratification tools were evaluated for quality of study design, internal and external
validation, and feasibility for use in context to the setting. The PEARL risk stratification tool
(Echevarria et al., 2017; Appendix C) incorporates prior admission, age, severity of disease or
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symptom burden and heart failure which are leading factors for COPD readmission, showed
comparable c-statistics to CHADS, and outperformed LACE and BODE.
Patient-specific Variables
Identifying pertinent risk factors and comorbidities predicted 30-day readmissions
(Jacobs et al., 2018; Krishnan, et al., 2019). Interventions identified patient motivation, clinical
and patient risk factors (psychosocial disparities and comorbidities), self-management and
reiterative patient education (Benzo et al., 2016; Blaha et al., 2018; Bourbeau & Echevarria,
2020; Mora et al., 2017). Two studies reduced readmission at 30 days: Benzo et al. (2016)
incorporated motivational interviewing (MI) with health coaching and a hotline for urgent
contact and Prieto-Centurion et al. (2014) provided frequent communication, a patient hotline,
and reiterative patient education.
Rationale
Theoretical Model
The Stetler Model (2001) guided research utilization emphasizing critical thinking,
decision making, and problem-solving through five phases: 1) Preparation, 2) Validation, 3)
Comparative evaluation or Decision-making, 4) Translation or Application, and 5) Evaluation
(Appendix D). This was a good fit for the project because the five phases relate to the process
and workflow within the healthcare facility as follows:
1. Preparation: Preparatory meetings with stakeholders confirmed the project aligned
with healthcare facility priorities. Developing stakeholder support and selecting
quality, relevant, and contextual evidence were foundations for the pilot.
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2. Validation: The healthcare facility has a strong physician-administration focus for
change that uses credible evidence. The risk stratification tool, PEARL (Echevarria et
al., 2017), was presented at a journal club for physician input.
3. Decision-making: Evidence synthesis and critical interpretation showed logical
decision-making to respect the healthcare facility physician-administration dyad and
honor nursing using risk stratification and transitional care to improve outcomes.
4. Translation/Application: The process showed how risk stratification research can be
applied to identify higher risk patients needing timely and intense clinic follow up
using evidence-based resources and activities to achieve outcome measures.
5. Evaluation: Data analysis measured formative data (the project found what was
intended) and summative data (goals were achieve), findings were disseminated, and
a final report was prepared and presented to stakeholders and faculty. Outcomes were
analyzed for the project to be accepted, modified, or rejected for sustainability.
Project Framework
The Logic Model developed by the WK Kellogg Foundation (2004) showed goals and
measurable outcomes linked to resources, activities, and outcomes for evaluation (Appendix E).
Evaluation was an important aspect of the project to answer what difference was made from
effective and efficient interventions based on evidence (Moran, et al, 2020).
Specific Aims
The specific aims of this QI project were to: 1) reduce COPD readmissions, 2) apply risk
stratification to identify higher risk patients, 3) identify and advocate for patient-specific
variables and 4) communicate recommendations for patient-specific resource allocation, budgets,
and policy development for this population.

13

Methods
Contextual Elements for the Project Intervention
Factors specifically considered for reducing COPD readmissions include expedited
access to pulmonary specialty care, risk stratification using the PEARL (Echevarria et al., 2017),
and interventions targeting patient-specific variables. A Risk Factors and/or SDoH table was
adapted to identify health disparities (Appendix F). These require dedicated resources and
activities to manage complex conditions specific to the project process and outcomes for the
healthcare facility and coordinated with the timeframe and requirements of the academic
institution.
Population
The state population is >30% rural, persons age 65 and older are 16%, approximately
50% are female, greater than 80% White race, Hispanics 12%, American Indian/Alaskan Native
(AI/AN) and Asians are both less than 2%, and Blacks less than 1% of the population, the
graduation rate is 90%, a poverty rate of 15%, and the state reports higher rates of COPD in
adults over the age of 45, women, AI/AN, less than a high school education, income less than
$25,000, smokers and areas with higher air pollution, more poor mental health days, and lower
vaccination rates than the nation despite having access to a PCP (CDC, 2011, County Health
Rankings [CHR], 2020; U.S Census Bureau, 2010; Rural Health Information Hub, 2002-2019).
Pilot inclusions were adult patients age of 45 or older, obstruction confirmed on
spirometry, admitted with a primary or secondary diagnoses with COPD or AECOPD
with/without acute respiratory failure between June and July 2021, local residence served by the
healthcare facility in the intermountain west. Exclusions included malignancy, discharge to
hospice, skilled nursing or long-term care facility, and patients who declined to participate.
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Setting and Resources
The pulmonary clinic is owned and operated by the healthcare facility providing
pulmonary, critical care, and sleep medicine services by 22 pulmonologists and 12 nurse
practitioners (NPs) and physician assistants referred to as Advanced Practice Providers (APPs).
The flagship healthcare facility is a non-profit Accountable Care Organization (ACO) with 8
medical centers, 1,005 hospital beds, over 200 clinics, 1.7 million clinic visits and over 56,600
hospital admissions. It is the second healthiest county in the state and performs better in health
factors, health outcomes, and life expectancy compared to neighboring counties (CHR, 2019).
Congruence of the Project with the Healthcare Facility Readiness for Change
Efforts to reduce COPD readmissions strategically align with the healthcare facility 2020
mission and vision to improve community health and be a trusted partner for exceptional,
patient-centered care. A recent community needs assessment by the healthcare facility
recognized the need for improved chronic disease prevention and management programs. It
created an interprofessional COPD workgroup to address this population’s healthcare needs. The
healthcare facility is positioned to optimize community care and shared value-based concepts as
a leader in one of the healthiest counties in the state.
Strengths and Weaknesses
The project strengths were 1) the impact on a local, national, and global healthcare
problem using EBP, 2) aligned with system thinking, 3) available experts and specialists, and 4)
technology with a robust EHR and telehealth services for access to quality care.
Weaknesses included 1) workforce shortages, 2) work silos, 3) limited contact with
leadership and challenges navigating services, 4) delayed expansion of telehealth if patients
decline or do not have access to internet, technology, or integrated medical devices, 5) cultural
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hierarchies with gaps in modernizing practices due to traditional styles, 6) delayed
communications and workflow, and 7) urgent unforeseen situations such as the COVID-19
pandemic.
Memorandum of Understanding
A Memorandum of Understanding (MOU) outlined an agreement between the project
lead and the healthcare facility (Appendix G). The Senior Director of Nursing & Patient Care
Center of Excellence and the project lead signed the MOU prior to beginning the project. This
included a brief project description as a readmission pilot project implementing patient risk
stratification and facilitating resource allocation. It included the background, purpose, intended
outcomes, and duration of the project. Reporting and agency preference for anonymity were
included.
Interventions
Correlation of Interventions with the Theoretical Model
Five phases of the Stetler Model correlated with the project as follows:
1. Preparation: Outcomes 3 and 9 prepared providers and staff for the EBP initiative
reiterating evidence and communicating interventions.
2. Validation: Outcome 4 was selected based on validity of the PEARL and context to the
patient population (Echevarria et al., 2017).
3. Decision-making: Outcome 4 showed the patient risk score for readmission that
provided guidance for which patients required intense clinic visits and outcomes 5, 6, and
7 identified patient-specific variables for resource allocation recommendations.
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4. Translation/Application: The evidence was applied, and data was collected and
monitored for modifications or adverse effects. Outcomes 4, 5, 6, and 7 communicated
unique patient circumstances to care teams to understand how to apply resources.
5. Evaluation: Outcomes 1 and 2 evaluated the pulmonary clinic’s ability to provide
patient access to care, outcome 8 communicated the patient care experience, and outcome
10 communicated the process and outcomes to stakeholders to determine sustainability.
Correlation of Interventions with Project Framework
The LM showed the direct relationship of resources, activities, and outputs implemented
to achieve outcomes and meet project aims. Ten of the eighteen outcomes were short-term
process outcomes (PO) or change outcomes (CO), as follows:
1. 50% of COPD participants referred to the outpatient pulmonary clinic were seen within 7-14
days of discharge (PO).
2. 50% of COPD participants on the healthcare facility pulmonary service line accessed 3 out of
4 outpatient pulmonary clinic visits within 30 days s/p discharge (PO).
3. At least one pulmonary provider(s) and staff (1-2 MAs) in the organization’s pulmonary
clinic received training by the project lead to use the EHR COPD template (Appendix H) by the
end of May 2021 (CO/PO).
4. 80% of COPD participants in the healthcare facility pulmonary clinic have the PEARL
(Echevarria et al., 2017) risk stratification documented in the EHR by the 2nd pulmonary clinic
visit or between June and August 2021(CO).
5. 80% of COPD participants in the healthcare facility healthcare facility pulmonary clinic
identified patient-specific motivation impacting care as documented in the EHR by the 2nd
pulmonary clinic visit between June and August 2021 (CO).
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6. 80% of COPD participants in the healthcare facility pulmonary clinic identified at least one
patient-specific risk factor(s) or social determinant for AECOPD documented in the EHR by the
2nd pulmonary clinic visit between June and August 2021 (CO).
7. 80% of COPD participants in the healthcare facility pulmonary clinic identified at least one
patient-specific perceived barrier(s) impacting patient care documented in the EHR by the 2nd
pulmonary clinic visit between June and August 2021 as measured by EHR audit (CO).
8. 80% of COPD participants in the healthcare facility pulmonary clinic reported the patient care
experience by the end of August 2021 (CO).
9. 80% of COPD participants in the healthcare facility pulmonary clinic had their care plan
communicated to the PCP and/or care team between June and August 2021 (CO/PO).
10. Recommendation’s report for COPD patients in the healthcare facility pulmonary clinic
includes readmissions, risk stratification, patient-specific variable for resources needed for valuebased care communicated to stakeholders by the end of May 2022 (PO).
Description of the Intervention
The project lead received daily communications of patients admitted with COPD from
hospitalists using a medical communication app, Voalte Me. In-patient APPs and the project lead
screened patients just prior to discharge for appropriateness of inclusion and exclusion
(Appendix I), completed risk stratification, and presented the participant letter (Appendix J) in
tandem with describing the program to the patient. An urgent referral was generated for
moderate and high-risk patients from the hospitalist to the pulmonary clinic. Low-risk patients
were advised to follow up with a PCP as usual. Interpreters were available if needed.
The pulmonary clinic scheduler monitored for incoming urgent referrals daily and
initiated a TCM encounter, scheduled appointment simultaneously for all four weekly visits (in-
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person, telehealth, or coordinated with home base services), and forwarded the communication to
designated MAs. Subsequently, MAs addended the TCM encounter with information from the
patient and/or caregiver that reviewed discharge follow-up, medication reconciliation, and
forwarded the communication to the pulmonary NP and PCP (Appendix K). Visit 1 with the
pulmonary clinic NP was within 7 - 14 days of discharge as a 60-minute pulmonary clinic or
home visit preferred over telehealth. Subsequent visits 2-4 were 30-minutes with telehealth
option within 30 days of discharge. The COPD template documented visits. Follow-up with
pulmonologists and transfer back to the PCP was arranged at visit 4 by the NP and was beyond
the scope of this pilot.
The clinic APPs incorporated MI for self-management and the emergency action plan
(rescue inhaler or nebulizer, pursed lip breathing, acute prednisone burst x5 day, antibiotic, and
call to the office or seen in ED) and identifying risk factors and barriers to care. Additionally,
care included real time interventions for GBT, deteriorating conditions, and comorbidity
management with health partners and the care team by phone or EHR notes.
Measures
Due to the timeframe of the project, only the ten short-term outcomes were measured
(Appendix L). Quantitative and qualitative outcome measures in the EHR were tracked by the
project lead and data analytics using a re-created and modified Data Collection Spreadsheet
(Verhaegh, et al., 2014; Appendix M).
Outcomes 1 and 2 were quantitative measures of pulmonary clinic visits 1-4 in the EHR.
Access to care within 7-14 days of discharge and intense weekly follow up in clinic visits over
30 days was a key strategy for risk assessment, early communication of participant decline, re-
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iterative education, GBT, and communicating patient-specific variable. The strategic and
recurrent appointments facilitated trust and rapport.
Outcome 3 were quantitative measures of the COPD template created and housed in the
EHR and provider(s) were asked to complete a Likert scale after visit 4 for feedback on the
COPD template. Additionally, meetings trained staff and providers on template use to decrease
variances and promote communication about the patient and their unique environment.
Outcome 4 used quantitative measures of the PEARL (Echevarria et al., 2017) score risk
for readmission during participant interview in the hospital and imbedded in the COPD template.
The PEARL (Echevarria et al., 2017) has an overall c-statistic of 0.68 -0.73 using five variables
(Prior Admission, eMRCD, Age, Right and Left ventricular function). If participants did not
have an echocardiogram within the past 1 year, then screening questions for heart failure
prompted a BNP level and if elevated then echocardiogram was performed; otherwise, there was
no scoring for left ventricular function (S. Bourke, personal communication, June 26, 2020). The
provider(s) were asked to complete a Likert scale after the pilot for feedback about the PEARL.
Outcome 5 used quantitative measures with a Likert scale in the COPD template, to
assess patient motivation at pre-test (visit 1) and post-test (visit 4) asking two interview
questions, “How important is it to you to manage your COPD” and “How confident are you that
you can help manage your COPD”. Patient engagement in self-management using motivational
interviewing was a successful approach for connecting and communicating with patients to
reduce readmissions (Benzos et al., 2016).
Outcomes 6 and 7 used quantitative measures in a multiple-choice drop-down checklist
and qualitative measures using triangulation of participant quotes using the COPD template,
monitoring and clarifying expressions or communications, and offering opportunities to verify
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information during clinic interviews. This rigor ultimately helped communicate participant risk
factors, challenges and perceptions of care needed for resource allocation and budgets.
Outcome 8 was a quantitative measure with a Likert scale in the COPD template, to
assess the participant care experience at the end of visit 4 as a post-project rating. The MA asked
the patient, “How helpful was this project to your understanding of your medical condition?”
Outcome 9 was a quantitative measure obtained by review of EHR clinic visits 1 and 4
communicated to the PCP by forwarded chart notes.
Outcome 10 was a quantitative measure of a created report for readmissions, risk
stratification, patient-specific variables and resources needed. The report provided a list of
recommendations.
Data Analysis
A variety of tools and techniques were used to analyze and report the quantitative and
qualitative data that represented the pilot participants. Small participant numbers enabled the
project lead to collect and analyze the data. This was important to facilitate the project aims
during times of limited provider and staff availability. Data analytics ultimately was able to pull
most data from the EHR, COPD template, and coding/billing. In areas where data was not
supplied, the director of nursing research provided oversight of the data analysis process.
Outcomes 1 and 2 were primary numerical data analyzing access to care using descriptive
statistics from the EHR.
Outcome 3 had two parts: Part 1 answered if the COPD template was created, and Part 2
answered if the in-person training meeting was completed. Both parts used yes/no dichotomous
nominal variables that were expressed as completed counts in the Data Collection Spreadsheet.
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Outcome 4 was analysis of quantitative data using descriptive statistics of two parts: Part
1 was the PEARL risk stratification score (Echevarria et al., 2017) retrieved from the EHR and
displayed as a pie chart, Part 2 was provider satisfaction with PEARL retrieved from Forms.
Outcome 5 analyzed quantitative data of participant motivation pre-test (visit 1) and posttest (visit 4) scores with descriptive statistics from the EHR and presented as a bar graph.
Outcomes 6 was descriptive statistics analysis of quantitative data for patient-specific risk
factors/SDoH from the EHR presented as a pie chart and qualitative data was analyzed for
themes and categories as reported by patients.
Outcome 7 used analysis of qualitative data retrieved from patient EHR who stated
barriers to care and this was communicated as themes or categories to the PCP and
administration.
Outcome 8 used analysis of quantitative data reported as descriptive statistics for the
participant care experience after visit 4 as documented in the EHR.
Outcome 9 was analyzed by descriptive statistics that captured communication forwarded
the PCP as documented in the EHR for visits 1 and 4 using counts of yes/no dichotomous
nominal variables.
Outcome 10 was analyzed using descriptive statistics in a final report using a count of
yes/no dichotomous nominal variables.
Ethical Considerations
Ethical Considerations and Protection of Participants
The obligation to serve and respect human life are ethical essentials in research and nonresearch projects (Moran et al., 2017). The Academic institution’s internal review board (IRB)
and healthcare facility’s research department for formal research determination was completed
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along with social, behavioral, and educational disciplines of human subject research for CITI
certification (Appendix N). Health Insurance Portability and Accountability Act [HIPPA] (1996)
and all healthcare facility policies and procedures protecting patients in research and evidencebased QI programs were followed to protect participants’ identities and rights during the pilot
project. Participants had pulmonary clinic visit notes documented in the EHR that were secure
and protected for privacy using authorized and encrypted procedures. An Excel spreadsheet was
created for data storage. This data consisted of only de-identified information extracted from the
EHR. The spreadsheet was password protected and stored on OneDrive. A code sheet matching
patient identification to project data was kept separate in a data file and destroyed when no
longer needed. The healthcare facility facilitated usual signed consent to treat and financial
disclosure for treatment.
Conflicts of Interest
The project lead is a NP in the pulmonary clinic with a long-standing relationship with
the healthcare facility and patient care population. There were no other conflicts of interest or
financial interests to report.
Biases
The project was carefully designed to improve practice outcomes. It was not designed to
contribute to generalizable knowledge. Even so, the data collection procedures aligned with the
patient population, evaluation methods of the project, outcomes and aims of the project that were
founded on high quality research to mitigate bias. There was communication with stakeholders
and champions to assure the project measured what was intended. The methods were relevant to
the pilot and fit within the healthcare facility. The plan incorporated a working relationship with
data and research experts to identify data as available, accurate, and reliable for credible use.
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Primary and discrete data was used, when possible, to reduce the impact on bias.
Additionally, validated measures, tools and appropriate analysis techniques were selected to
reduce bias. A team of members, including a second reader from outside the pulmonary clinic
and healthcare facility, was assembled to mitigate biases, threats to quality, and/or patient harm.
Staff and the provider(s) were trained and retrained for the implementation process and data
evaluated throughout the project timeline to quickly address any missing and outlying data.
Questions posed to enrolled participants during an interview by healthcare professionals
may have had a halo effect contributing to bias if the patient felt the need to be a “good” patient.
Efforts were made to decrease variability in provider questions through use of the COPD
template, use of support staff when appropriate during interviews, and use of Microsoft Form
surveys as opposed to interviews for providers when appropriate.
Threats to Quality
The potential threats to project quality were keeping the project prioritized within a large
healthcare facility amongst other program and project priorities, varying service locations that
risk work silos and communication delays, unforeseen circumstances such as the COVID-19
pandemic, delays and/or limitations in expanding telehealth for pulmonary clinic visits,
manpower and budget constraints.
The plan to handle the potential threats included reinforcing the scope of the project that
aligned with the healthcare facility mission and vision. These patients continue to require
healthcare services once discharged from the hospital and providers need to be available in their
communities. The pandemic has impacted patient contact in clinics and further risk of
deteriorating health. Telehealth and domicile care helped to address the problem and connect
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patients in their homes to providers however, this type of care must be carefully considered and
strategically applied (Mahtta et al., 2021).
Internal Review Board Application and Project Determination
A letter of Research Determination was received from the healthcare facility’s research
department indicating the project does not meet criteria for human subject research. This
information was communicated to the university Office of Research Compliance and faculty for
approval prior to initiating the project. The university IRB confirmed the project was a QI pilot
and did not meet criteria for human subject research (Appendix O).
Results
Timeline
A timeline kept the project on track (Appendix P). The planning phase began June of
2020 through May of 2021 with the literature review and synthesis of evidence, defined scope of
the project with stakeholders and faculty, selection of data collection and analytical strategies,
and projected budget. Formal research determination was completed from the healthcare facility
that satisfied the academic institution’s IRB process. A coding/billing specialist approved the
TCM and COPD templates for documentation and billing requirements. Implementation phases
consisted of training staff, patient pulmonary visits, collecting defined data, and monitoring for
unforeseen changes communicated with stakeholders and faculty May through August 2021. The
data analysis phase continued through March 2022 with interpretation and evaluation of outcome
measures with updates to stakeholders and faculty. The project culminated in May 2022 with
dissemination and report of findings to the healthcare facility, faculty, and Scholarworks.

25

Steps of the Intervention
The project intervention initiated with the planned implementation activities of training
staff and providers on workflows for patient appropriateness for inclusion/exclusion, PEARL
(Echevarria et al., 2017) risk stratification, screening and enrolling patients, TCM requirements,
and COPD template use. A PowerPoint presentation provided an overview to pulmonary
providers and administration using Microsoft Teams. Emails were used to coordinate the topic
and logistics with hospitalists and PCPs who identified and referred patients to the project lead.
The pilot was implemented in the summer, as planned (see description of the process in
Methods). Hospitalist referrals and screening were completed by the end of July to allow for
final pulmonary clinic visits to be completed four weeks later to meet the projected end date.
Process Measures and Outcomes
Over the eight-week course of the initiative, 36 patients were referred and screened for
participation. Eighteen were excluded per criteria. The remaining eighteen were assessed for risk
of readmission and of those, eleven (61%) were further excluded due to low risk. Seven were
enrolled and completed the program: six (33%) were moderate risk and one (6%) was high risk.
57% were women. The age range was 62-84 with an average age 76. No participants were
readmitted or died at 30 days which was a specific aim of this pilot. Data was pulled from the
EHR and COPD template as planned (Outcomes 1-9).
Outcomes 1 and 2: Met. All participants were contacted by medical staff within two days
of discharge. The average number of days from hospital discharge to visit 1 was five days. One
hundred percent of participants were seen in clinic within 7-14 days of hospital discharge and
accessed three out of four pulmonary clinic visits within 30 days of discharge meeting TCM
criteria. The Data Collection Spreadsheet was created and modified for efficiency and useful
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information, coding and billing compliance, and data collection and analysis measures for the
D&A team.
Outcome 3: Met. A total of three clinic staff (medical assistants [MAs]), two
administrative staff (schedulers), six APPs (four in-patient and two out-patient for the multiple
sites) received training for use of the COPD and TCM templates. Coding updates included a
telehealth clause to the COPD template and TCM details were re-iterated. A post-project survey
using Microsoft Forms was created to measure APP feedback which was rated 4/5 on a Likert
scale (1, not easy to use and 5, easy to use). Comments included an informative and inclusive
template but busy and needed to be streamlined to guide the comprehensive process.
Outcome 4: Met. 100% of participants interviewed had their readmission risk score
documented in the EHR by visit 2 using the PEARL tool (Echevarria et al., 2017). Patients’
levels of risk are shown in Figure 1: low (61%), moderate (33%), and high (6%) risk.

Note. Reference PEARL (Echevarria et al., 2017)

A post-project survey using Microsoft Forms was created to measure APP feedback for
using PEARL (Echevarria et al., 2017) which was rated 2-5/5 on a Likert scale (1, not easy to
use and 5, easy to use). Sixty-six percent of providers completed the survey and comments
included easy to use but there was the need for re-iteration on how to score (specifically for prior
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admissions and eMRC rating) and the tool was a way to infer risk stratification for hospital
personnel and educate patients about why they are being referred to pulmonology.
Outcome 5: Met. 100 % of participants interviewed had their motivation score
documented in the EHR by visit 2. Participants were interviewed to identify their motivation for
importance of and confidence in managing their COPD using a Likert scale (1, not important/not
confident and 10 extremely important/extremely confident). The scores for pretest at visit 1 and
post-test at visit 4 are displayed in Figure 2. Participants’ scores for importance of managing
their COPD were high with pretest scores ranging 8 - 10 (average 9) and post-test was 9 – 10
(average 9.8). The level of participants’ confidence for managing their COPD varied low to high
with pretest scores ranging 2 - 10 (average 7.5) and post-test was 7 - 10 (average 8.4). The
majority of participants (86%) participants scored seven or greater for high importance and
confidence in managing their COPD.

Note. Bar graph shows participants' average Likert scores (1, low and 10, high) for motivational interest (at visit 1 is
9 then increases by visit 4 to 9.8) and confidence in managing their COPD (at visit 1 is 7.5 then increases by visit 4
to 8.4).

Outcome 6: Met. 100 % of participants interviewed had a patient-specific risk factor
and/or SDoH using a checklist documented in the COPD template by the visit 2. Participants’
risk factors/SDoH scores associated with readmissions included 86% with high (4 or more) risk
factors and 14% with moderate (0-3) risk factors which is displayed in Figure 3. All participants
(100%) noted comorbidities and most (86%) noted aging as a risk factor for exacerbations. Five
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(71%) of participants reported difficulties adhering to care plan recommendations, including two
(29%) who continued smoking.

Note. Pie chart shows percent of participants' Risk Factors/SDoH scores 0-3 (12%) associated with moderate risk for
readmission and 4 or more (88%) associated with high risk for readmission.

Outcome 7: Met. 100% of participants were interviewed to describe barriers to care that
impact their care by visit 2. Six (86%) of participants reported no barriers to care, and one (14%)
reported the lack of ability or desire to change as a barrier to care.
Outcome 8: Met. 100% of participants were asked to score their patient care experience
at visit 4 which averaged 4.8/5 (1, not helpful and 5, most helpful) helpfulness to understand
their medical condition.
Outcome 9: Met. 100% of participant office visits notes were sent to their PCP and/or
care team to communicate patient updates and care plans. Due to a trusted professional
relationship between the PCP and specialist in our healthcare facility, and the high volume of unrelated messages providers receive, the PCPs requested to have only visits 1 and 4, and/or visits
with a specific concern or need to act, forwarded to them.
Outcome 10: Met. A scholarly report of project outcomes communicated findings and
patient-specific risk factor with recommended resource allocation to support value-based care
(Appendix Q). The resource allocation smart data element was not created in the EHR as no tech
support was available.
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Missing Data
The human fatigue factor during COVID and coding variations in admitting diagnoses
could have played a role in potentially missed participants. Repetitive, daily reminders using the
communication app were sent soliciting hospitalists for AECOPD admissions. Hand searches for
AECOPD hospital admissions supplemented requests from hospitalists. Two sets of data were
excluded since one patient did not show up for visit 1 as scheduled and the second was
incorrectly diagnosed. Follow-up data was requested from data and analytics for visit 3 to assure
TCM was met, and hand pulled to review for accuracy for motivational interview scores,
participants’ care experience, and communicating with the PCP when computer data was not
identified.
Unexpected Findings
Sixty-one percent of patients risk stratified with the PEARL tool (Echevarria et al., 2017)
during hospital screening, were low risk for readmissions or death and therefore did not meet
enrollment criteria. The tool adds scoring for hospital admissions in the past year, and so the
scoring may have yielded different results during a non-pandemic timeframe.
The motivational interest and confidence were overall higher than expected as measured
in pre-test and post-test and the halo affect may have been a factor. Alternatively, patients who
are overly confident may not realize the incongruence with negative lifestyle or non-adherence to
treatments, or they may lack education on the complexity of the disease. High scores may be an
opportunity harness motivation to support change.
There were anecdotal reports of fewer AECOPD related hospitalizations during the
summer months of this pilot during COVID-19 pandemic which may be due to the following:
decreased community contact between people, masking, handwashing lessening usual infections,
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less activity and therefor fewer symptoms, and decreased commuters with subsequent decreased
air pollution and fewer symptoms. The latter is of interest as predictions for this area report an
increase in commuting population which worsens air pollution. Additionally, the increasing
retirement population and more people expected to be diagnosed with COPD should trigger an
uptick in readmissions.
Recommended guideline-based therapies varied such as limited or no use of
recommended pulmonary rehabilitation, PDE-4, NIPPV, palliative care, and health coaches and
included concerning uses of chronic oral glucocorticoids (GOLD, 2020; Celli & Wedzicha,
2019; Mandru et al., 2021).
Unintended Consequences
An unintended consequence was furthering group fatigue and sense of project lead
isolation within the pulmonary group which was likely multifactorial with an evolving NP-led
initiative, pre-pandemic HR problems, followed by the COVID pandemic, that added to already
heavy workloads. These crises delayed contact and limited communications between healthcare
professionals unless there were very specific and intentional needs to be met, and/or high acuity
problems.
Project Budget
The expenses necessary to pilot the project were $19,795.00 with generated revenue
including in-kind donations totaling $26,995.00. The budget categories included expenses,
revenue, and operating income. A full financial analysis for Year 1, Years 2-3 budget and the
Statement of Operation can be found in appendices, R, S, and T, respectively.
Year 1 projected expenses ($19,795.00) includes personnel, office space, office system,
office supplies, office equipment and travel. Year one to year two predicted expenses are
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adjusted for increase in patient volume and Year 3 projections included a 3% salary increase.
Revenue ($26,995.00) included primarily in-kind donations of DNP student hours, healthcare
facility personnel, space, equipment and materials, diagnostics if necessary and pulmonary clinic
visits. The resulting operating income is $7,200.00.
The primary changes in expenses anticipated the sustainable project growth through and
beyond years 2 & 3. Revenue would also include cost savings from avoiding 3% financial
penalties for COPD readmissions estimated at $10,000 (Elixhauser & Podulka, 2006), avoiding
medical errors occurring during hospitalizations which is estimated annually at $17 billion and
210,000-400,000 deaths per year nationally (James, 2013), avoiding lack of productivity from
deteriorating physical and socioeconomic conditions from hospitalizations estimated at more
than $6,000 per patient per year (Press et al., 2018), and poorer outcomes if greater than three
hospitalizations /year (Soler-Cataluna, et al., 2005).
Discussion
Summary of Key Findings
Data demonstrated no patients were readmitted which was a specific aim of the pilot.
Applying risk stratification facilitated effective use of TCM from hospital discharge to
pulmonary clinic for intense real-time management of patient-specific conditions as reported by
Echevarria et al. (2017) and Mora et al. (2017). Motivational interviewing facilitated selfmanagement topics (Benzos et al., 2013 & 2016). Identifying and communicating patientspecific variables was accomplished to allocate meaningful resources for value-based care which
were specific aims and strengths of the pilot. It successfully aligned with the healthcare facility
mission and priorities which was a strength of the project. The Stetler model was an appropriate
foundation for the project.
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Interpretation
Association Between Interventions and Outcomes
The LM shows the strategic use of resources (hospital and clinic personnel, APPs, and
technology) and activities (timely and highly intense visits, communication, and technical
support) during clinic visits to identify, plan for, and deliver timely, coordinated patient-centered
care (Kellogg Foundation, 2004). This demonstrates the difference we can make as a collective
team of healthcare professionals to improve patient and healthcare facility outcomes.
Impact of Project on People and System
This pilot included intentional communications with multiple disciplines and programs:
discharge coordinators with health partners, transitional care coordinators, rehabilitation, and
technology with EHR, telehealth, and remote monitoring. The project increased demands on IT
and data analytics teams which were unable to fully support developing smart data elements.
Critical thinking provided guidance to strategic resource allocation within an ACO, reflecting
commitment to healthcare facility mission and values.
Contextual Elements Influencing the Logic Model
There were three important influences on the project: 1) the DNP role was new to the
acute care service line, 2) the pulmonary clinic was in a pre-pandemic human resource (HR)
crisis, and 3) the COVID-19 pandemic crisis started after the proposal was initiated. The DNP in
leadership role was introduced to the pulmonary clinic and acute care service line. The
healthcare facility initially recognized the project lead under the DNP student umbrella which
would have required regulatory co-signatures; as such, healthcare facility leadership additionally
recognized the project lead under the employed NP umbrella implementing a QI project. This
allowed full participation in the pilot as a licensed provider working within the scope of practice
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in the state. The purpose and size of the pilot was explained to the pulmonary clinic and
administration to assure: 1) safety for implementing evidence-based initiative, 2) fit for the
culture, and 3) feasibility for the healthcare facility (Stetler Model, 2001).
The pre-pandemic HR crisis shifted focus for pulmonary clinic operations and patient
access as clinic providers (physicians and APPs), clinical staff (MAs and respiratory therapists),
managers, and leaders left the clinic. APPs had limited support and tension during this time and
during COVID. While research studies used NPs, RNs, and RTs trained in MI (Benzo et al.,
2016, Mora et al., 2017), the pulmonary clinic does not have a RN and the RT are not trained in
MI. Additionally, not all APPs had MI skills and hospital work, part-time status, and/or paid time
off decreased the number of APPs available for the continuity of intense weekly clinic visits. The
project lead as a pulmonary NP was unable to be credentialled for home visits due to time
constraints and prioritized pulmonary clinic needs; therefore, a partnership was established with
a home base NP to be used when home health criteria was not met.
The original proposal included hospital patient referrals from multiple disciplines of
respiratory therapy, nursing, and admitting; however, these staff became fatigued and/or were
new or travelers unfamiliar to the service line during the COVID pandemic. Therefore, the
administrative leadership requested only hospitalists or providers from the acute care service line
refer patients to the pilot for screening inclusion. Initial patient screening within 1-2 days of
hospital discharge was temporarily modified to try accommodating inpatient APP requests for
screening at any time during hospitalization to avoid short-notice referral demands on already
heavy workloads and tensions from the pre-pandemic and pandemic crises. However, if the
screening was started too early, it was difficult to complete the enrollment process due to
pending diagnostics, evolving care plans, and unknown discharge location such as rehabilitation
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or hospice which would be exclusions. Zikos (2019) identified a mismatch between admitting
and discharging diagnosis up to 60% of the time. Screening patients closer to the time of
discharge allows time for stabilization and diagnostics to confirm the discharging diagnosis
matches the presumed admitting diagnosis and discharge location.
Baseline data for the healthcare facility was limited to Medicare/Medicaid reporting
(Medicare, 2019). Knowledge and sharing of information about the population surfaced at the
time of implementation including the limited involvement of pulmonologists, care coordinators,
TCM, health partner programs, and variations in telehealth and remote services. Due to the
pandemic and shifting priorities, the COPD workgroup was placed on hold, and technology and
data analytics team were not provided hours to develop a patient-specific resource table to assist
in connecting patients to resources supporting value-based care. Telehealth services were
developing which facilitated patient visits during COVID.
Reasons for differences between Anticipated and Observed Outcomes
The specific aims and outcomes were met so there are no differences between anticipated
and observed outcomes. However, more patients admitted with AECOPD were anticipated
during the pilot which was likely associated with COVID-19. Unlike Echevarria (2017), there
was a high percentage of patients with low risk for readmission in this pilot either due to local
population, care outcomes, or the COVID-19 pandemic.
Costs and Strategic Trade-offs
The stakeholders agreed ten or fewer participants for the pilot seemed manageable while
offering information on project fit, feasibility, safety for participants. Additionally, only
moderate, or high-risk patients were offered pulmonary specialty care due to the complex nature
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of these patients and lower risk patients continued to follow with their PCP to help reduce the
volume of patients referred to the pilot.
Frequent contact and MI skills help identify, communicate, and treat deteriorating
conditions, reiterate self-management, and reinforce behavioral changes as reported by Benzo et
al. (2016). There is increased cost associated with frequent visits, technology, and training;
however, as previously mentioned, these costs offset more expensive costs and risks associated
with 30-day readmissions, poorer productivity, and poorer prognosis for patients with more than
three AECOPD/year (Press et al., 2018; Soler-Cataluña et al., 2005).
Limitations
This project was specific to the site and healthcare facility and thus is not generalizable.
Systems layers, cultural hierarchies, and financial constraints often become barriers to the scope
of work that can be collaboratively accomplished. The number of pulmonary providers and
respiratory therapists trained in motivational interviewing, changing and limited clinic personnel,
lack of a registered nurse, volume of patients requiring access to care, and system priorities
limited the scope of this pilot. It was important to stay objective and focused on patient
improvement and lifelong learning.
The PEARL risk stratification tool was new to the acute care service line, and although
reviewed in journal club, practice with use is important to confirm scoring is done consistently.
As mentioned, COVID-19 may have impacted hospitalizations which may have skewed
patient risk stratification results. The COPD readmission rate remains high for the healthcare
facility at the time of this report (Medicare.gov, 2022). The actual hospitalization rate for
AECOPD pre and during COVID-19 is unknown to the project lead which represents siloed
information and limited contact with healthcare facility leadership.
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The health care facility and physician leaders recently developed an EHR SDoH
dashboard, but this was not available for use. Therefore, the project lead adapted a table for use
that incorporated known risk factors associated with readmissions based on face validity
(Deniger, 2015; Kansagara, 2011; Magnan, 2017; Shah, et al. 2016).
Conclusions
Usefulness of Work
The pilot demonstrates the role of the DNP in Leadership to translate evidence into
practice which is important when considering the delay of >10-15 years of getting research into
practice (WHO, n.d.). It also offers interprofessional support to physicians, administration, and
the healthcare facility system. There is plenty of work to coordinate in a learning community.
The resources, activities, and interventions of the pilot have the potential to impact local and
regional care to decrease COPD readmissions.
It is important to take the time to discover patient-specific variables and promote
connections to reduce patient burden of multiple, complex issues placing patients at risk for
readmissions. Recall, Press et al. (2018) reported the need to help prioritize complex, timeconsuming interventions. Administration, IT, pulmonary and primary care physicians, APPs,
respiratory therapists, transitional care registered nurses, and medical assistants reported
appreciation and willingness to be involved with a new initiative to improve outcomes. This
provides a sense of unity, helpfulness, and responsiveness to make a difference in patient care.
Patient engagement within the clinic and community is necessary to shift focus from
inpatient to outpatient preventive levels of care. This shift allows the identification of patients’
specific needs to create realistic budgets and policies for the clinic and community arenas. This
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outpatient work further aligns with the healthcare system mission and vision of being a trusted
partner in all communities served.
Sustainability
This pilot demonstrated the ability to reduce hospitalizations and/or survival at 30 days
but what happens after that? Press et al. (2018) recommended moving beyond 30 days. Several
well-designed studies identified the need to follow patients closely initially and continue to
follow over one year (Benzo et al., 2016; Hernandez et al., 2015; Ko et al., 2017; Mora et al.,
2017). Extending care plans have implications to meet intermediate and long-term outcomes
presented in the logic model.
This is a relevant project to replicate due to the projected rapid population and retirement
growth that will increase the volume and cost of patients needing COPD care. Recall, RWJF
(2018) reported thirty percent of healthcare patients have a trajectory towards high resource
utilization and these patients need to be identified. The project lead is dedicated to this work with
a pertinent background working as a NP, commitment to lifelong learning, and experiences with
rural healthcare.
Potential for Spread
The interventions are appropriate to spread to other chronic conditions and underserved
areas. The work transforms healthcare, reduces costs, improves patient care outcomes, and
demonstrates value in quality patient and provider care, supporting efforts of The Quadruple Aim
(Bodenheimer & Sinsky, 2014). The pilot demonstrated the contributions of nurse leaders and a
healthcare team when identifying and managing gaps in care and supporting EBP. Nurse
leadership is a strong and valuable workforce and now is the time for nurse-led initiatives
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(RWJF, 2017). Collaboration and coordination of care to keep patients out of the hospital,
managed in the clinic, and supported in the community is a project well-suited for nurse leaders.
Future Research.
•

Research is needed comparing disease specific risk stratification tools to SDoH tools as
patients living in underserved areas may all have high SDoH; predictive tools must account
for multiple patient factors.

•

Explore provider perceptions for following versus not following GBT.

•

Explore complementary and alternative care with this population.

•

Policy should explore community shared savings and cost center partnerships, care
coordination with health partners, referrals, e-consults and communication to demonstrate
value-based care.

•

Future studies are important for nurse-led initiatives’ impact on patient, system, and
community outcomes.

Implications for Policy and Practice
This pilot may not have the same outcomes if the evidence-based processes that were
implemented are not followed. The healthcare facility must be engaged and prepared to connect
patients with meaningful, useful, and reimbursable community resources and activities outside of
the hospital setting (Hernandez et al., 2015; Shah et al., 2016; Zhong et al., 2019). Patients then
receive care and support required in their environment versus risk further deterioration in health,
and poorer productivity (Ben-Assuli et al., 2020; Press et al, 2014; Shah et al., 2016; Bourbeau &
Echevarria, 2020). Care must extend beyond the 30 days risk of financial penalty because while
patients are in the hospital, they avoid negative environmental factors and have access to
multiple professionals with supportive care; but, once discharged, patients risk re-engaging in
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negative lifestyles and fail adherence to quality treatment care plans. One of the most
challenging tasks may be how to address lifelong behaviors specific to community cultures.
Providers must have scheduled time for a deep dive into patient-specific variables. It is important
to recognize and understand each patient’s uniquely different circumstances to support them in
their living environment. What works in one area may not work in another due to lack of access,
culture of care, and/or limited resources. These factors are important to communicate to patients,
care givers, system leadership and policy makers to help with the decision-making process of
resource allocation (Deniger et al., 2015; Hernandez et al., 2015; Ko et al., 2017; Mora et al.,
2017; Naylor et al., 2004; Verhaegh, et al., 2014). Recommendations include the following:
Access to Care.
•

Professionals need to be hired and/or trained for knowledge, skills, and abilities in
motivational interviewing as reflected in research recommendations (Benzo et al., 2016).

•

Hospital discharge to clinic follow up with TCM including pulmonary specialists, PCPs, care
teams, and health partners (Mora et al., 2017).

•

Policy makers must incentivize and reimburse all guideline-based therapies for example
access to health coaches with low confidence and portable home equipment when there is no
rehabilitation.

•

Palliative care services are needed to support for, example, top resource users, patients with a
poor trajectory, and patients with low or no motivation for changing lifestyle.

•

Healthcare providers living in neighborhoods with higher risk populations of chronic disease
are instrumental in creating new pathways to care for individual or family lifestyle change
(U.S. Department of Health and Human Services, 2010; Halfon, 2012).
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•

Commuting must be judiciously applied as it increases air pollution and risks of diagnoses,
exacerbations, and readmissions of residents thus worsening outcomes (Li et al., 2017).
Risk Stratification.

•

Primary care providers and pulmonary specialists must leverage risk stratification work.

•

Patients with poor trajectories and higher risks must be identified using risk stratification and
predictive models even prior to hospitalization (Ben-Assuli & Padman, 2020; Echevarria,
2017; Press et al., 2018; Zhong et al., 2017).

•

Risk stratification must be applied at the time of hospitalization for follow up care decisionmaking and communication that is important between care teams (Echevarria et al., 2017).
Patient-specific Variables.

•

Patient accountability and system financial reimbursements must be incorporated into public
health policy and reimbursements for costs when patients have low motivation or
incongruent actions in knowing versus applying quality care recommendations (Shah, et al.,
2016; Zhong, et al., 2017).

•

Insurance coverage must expand to meet patient-specific needs, incentivize health living and
de-incentivize an unhealthy lifestyle.

•

Reliable lines of communication must connect leadership and front-line workers to advocate
and coordinate critical interprofessional care, especially for patients with higher vulnerability
and diminished health equity (Blaha et al., 2018; Bourbeau & Echevarria, 2020; Press, 2018;
Prieto-Centurion, 2014; Mora et al., 2017).
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Technology.
•

Technology (telehealth and remote patient monitoring) must be strategically applied to help
access care and education for patients and providers with inequitable or inaccessible care
services (Mahtta et al., 2021; WHO, n.d.).

•

Care teams should take advantage of, but strategically use, technology according to patient
ability to hear, understand, and degree of illness as the highest risk benefit from in person
visits.

•

Updated templates and tables are needed in the EHR to 1) know quickly where to look for
information, recommendations, referrals, and re-iterations and 2) link patient specific needs
to the correct resources.

•

COPD education must be provided and re-iterated with respect to the patient’s best learning
style to support care experiences (Bourbeau, 2019; Jiang, 2013; Press, 2018; Stone, 2012).

Next Steps
The next steps for this pilot includes dissemination of the findings and advocating to
continue work toward the intermediate and long-term goals per the LM. Reinstating the COPD
workgroup is one avenue to support recommendations and policy development, breakdown
siloed information and care, and integrate work with PCPs, home base services, mobile units, IT,
transitional care, health partners, and pulmonary clinics while developing community
partnerships and population health programs for patient-centered care. Additionally, advance
practice nurse leaders added to boards facilitate communication and compassionate patientcentered care in these complex scenarios (Institute of Medicine [IOM], 2011).
In conclusion, the participants in the pilot were not readmitted. They reported a very
good patient care experience. The PEARL tool (Echevarria et al., 2017) was useful for risk
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stratification to help predict and prioritize resource allocation which demonstrates value-based
care (Scalable Health, 2018; National Council Organization, 2017). Providers made timely
interventions for deteriorating conditions and strategically assessed patient-specific variables
using intense visits and motivational interviewing skills. Self-management targeted patientspecific needs. The information was communicated in real-time to their care team and as a report
to stakeholders of the healthcare facility. Recommendations were included for sustainability,
policy and budgets, and additional research. The pilot demonstrated the role of NP leaders in
EBP and QI initiatives in conjunction with physicians, administration, and care team members to
improve value-based care in the community.
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between air
pollution,
outdoor

Descriptive,
retrospective study
of AECOPD and
air quality
Level III B
c-stat n/a

309 AECOPD were
recorded in the
analysis
Inclusion
FEV1/ FVC<0.70
Exclusion

AECOPD
definition,
causes, effects on
patient
Results:
AECOPD is
complex with
significant
impact on
morbidity,
mortality, cost,
not fully
understood
Air pollution
level (PM) and
temperature,
Daily AECOPD
rate
Results:
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TITLE OF
ARTICLE

AUTHOR
YEAR

RESEARCH
AIM
Search Terms
Database
Dates
Fit (PICOT)
temperature
and AECOPD
Topic:
Risk factors
Air Pollution
Database:
Medline
Google Scholar
Search:
Social
Determinant

Impact of Air
Pollutants on
Outpatient
Visits for
Acute
Respiratory
Outcomes

Li et al.
(2017)

Investigate the
impact of air
pollutants on
acute
respiratory
outcomes in
outpatients
Topic:
Risk factors
Air pollution
Database
Medline
Social
Determinant

Study Design
Type of Evidence
Level /Quality
Statistical
Analysis
c-stat
Limitations
Limitations
Small n,
Frequency of mild
AECOPD
unknown but leads
to decline.
These factors could
lead to
underestimation

Population
Inclusion/Exclusion

OUTCOME
MEASURES/
RESULTS

Residence outside of
study area

Descriptive
retrospective study
of AECOPD and
air quality
Case-crossover
design
Spearman rank
correlation analysis
Multiple and
Conditional
regression between
acute respiratory
outcomes and air
pollution

57,144 patients
Outpatient data from
December 2, 2013, to
December 1, 2014
Inclusions:
respiratory
department with
acute symptoms and
fever clinic including
URTI, acute
bronchitis, CAP,
AECOPD or AEasthma or AEBronchiectasis

Lower daily
mean
temperatures
were associated
with the levels of
air pollutants.
The level of
PM10 correlated
with the levels of
the other air
pollutants. The
daily number
of AECOPD was
found to correlate
weakly, but
significantly with
the mean level of
PM10 in the
previous six days
Air pollutant data
including ozone
(O₃), nitrogen
dioxide (NO₂),
carbon monoxide
(CO), sulfur
dioxide (SO₂),
and particulate
matter (PM2.5
and PM10)
upper respiratory
tract infection,
acute bronchitis,
community-

RECOMMEN
DATIONS/IM
PLICATIONS

Times cited
Trust
Notes

1 degree
resulted in
4.7% increase
in the mean
number of
hospitalization
s

Cited x 46
Trust - Yes
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TITLE OF
ARTICLE

AUTHOR
YEAR

RESEARCH
AIM
Search Terms
Database
Dates
Fit (PICOT)

Study Design
Type of Evidence
Level /Quality
Statistical
Analysis
c-stat
Limitations
Limitations:
Outpatient data
One hospital

Population
Inclusion/Exclusion

OUTCOME
MEASURES/
RESULTS

Exclusions:
Outpatient visits for
chronic diseases
without an acute
exacerbation, noninfectious diseases,
and diseases without
a definite diagnosis
were excluded

acquired
pneumonia,
AECOPD, AE
bronchiectasis
Air pollutants
had acute effects
on outpatient
visits for acute
respiratory
outcomes, with
specific
outcomes
associated with
specific
pollutants
PM2.5, PM10,
NO₂, SO₂, and
CO exposures
were positively
associated with
outpatient visits
for acute
infectious and
non-infectious
exacerbations of
underlying lung
diseases
PM10, SO₂, and
CO exposures
were positively
associated with
outpatient visits
for AECOPD

RECOMMEN
DATIONS/IM
PLICATIONS

Times cited
Trust
Notes
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TITLE OF
ARTICLE

AUTHOR
YEAR

Consideratio
ns for and
Mechanisms
of Adjunct
Therapy in
COPD

Mandru et
al. (2021).

Managing
Patients with
COPD
Exacerbatio:
Does Age
Matter

Stone et al.
(2012)

RESEARCH
AIM
Search Terms
Database
Dates
Fit (PICOT)
Review of
adjunct
therapies as
part of
approach to
managing
COPD
Gain insight
into the
relationship
between age
and
management of
AECOPD, as
older persons
are known to
be at a greater
risk of hospital
admission
Topic:
Risk factors
Age
Poor
Awareness
Database
Medline
Google Scholar
Social
Determinant

Study Design
Type of Evidence
Level /Quality
Statistical
Analysis
c-stat
Limitations
Expert Review
VA

Population
Inclusion/Exclusion

Clinical and Patient
questionnaire
Check:
Descriptive
correlation or
Cohort Study
Answer:
Qualitative Study
Level III B
Chi-squared test
for age decile
group

2,842 Adult patients
with COPD
Age ranged from 27
to 102
2008 UK COPD
audit
Inclusion
Hospital units
admitting unselected
emergency
admissions
prospectively up to
60 consecutive cases
of COPD
exacerbation
between March and
May 2008,
Exclusion
Not id’d

Mann–
Whitney/Kruskal–
Wallis test for age
in years
SPSS V18
Limitations:
Did not audit for
dementia
Not all elderly
patients captured

COPD

OUTCOME
MEASURES/
RESULTS

Provided brief
but information
considerations
for past and
present therapies
in advanced
COPD
Patient-reported
data:
knowledge base
and self-care data
Clinicianreported data:
disease severity,
comorbidity,
mortality
Results:
Older patients
had inferior
knowledge of
COPD, less selfcare and
were less likely
to recognize
symptoms of
exacerbation
prior to
hospitalization
Although older
patients had
severe disease
and symptoms,
greater co-

RECOMMEN
DATIONS/IM
PLICATIONS

Times cited
Trust
Notes

Selection of
adjunct
therapies must
be weighed
carefully

Yes

Clinicians
should consider
increasing age
as a specific
risk factor
(particularly
>80) in the
management of
COPD

Cited x 19
How patients
selected:
Hospital units
admitting
unselected
emergency
admissions
identified
prospectively
up to 60
consecutive
cases of COPD
exacerbation
between March
and May 2008,
and audited
retrospectively
their inhospital care
and outcomes
90 days
following the
index
admission

64
TITLE OF
ARTICLE

Acute
Exacerbation
of COPD:
Influence of
Social
Factors in
Determining
Length of
Hospital Stay
and
Readmission
Rates

AUTHOR
YEAR

Wong et al.
(2008)

RESEARCH
AIM
Search Terms
Database
Dates
Fit (PICOT)

Determine the
factors that
influence
length of stay
in the hospital
and
Readmission
for patients
with AECOPD
Topic:
Risk factors
Disease
severity
Comorbidity
Database:
Medline
Search:
Social
Determinant

Study Design
Type of Evidence
Level /Quality
Statistical
Analysis
c-stat
Limitations

Nonexperimental/quant
itative
Retrospective
Study
Level III B
Logistic regression
analysis using
readmission
(positive or
negative)
Multiple logistic
regression analysis
was conducted
using age and sex
as covariates
possibly related to
readmissions
Stepwise logistic
regression on other
variables
Data for each
patient were coded

Population
Inclusion/Exclusion

109 admissions
reviewed
Canadian hospital
Inclusion
diagnosis of
AECOPD
Exclusion
Not id’d

OUTCOME
MEASURES/
RESULTS

morbidity at
presentation and
higher mortality,
fewer were seen
in hospital or
followed up
subsequently by
respiratory
specialist
Global Initiative
for Obstructive
Lung Disease
(GOLD) status,
Comorbidity,
Marital status,
Length of Stay
(LOS)
Results:
Disease severity
(GOLD status)
and number of
comorbidities are
associated with
readmission rates
of patients
with AECOPD.
Social factors
such as marital
status and the
need
for social work
intervention are
also linked to

RECOMMEN
DATIONS/IM
PLICATIONS

Times cited
Trust
Notes

Patients
surveyed prior
to discharge
about COPD
management
and if help
needed after
discharge
Prospective
studies using
social factors
and
socioeconomic
status with
optimal therapy
Pulmonary
rehab
Opportunities
for policies for
targeted public
health and
health service
interventions

Cited x 92
Study
supported
socioeconomic
factors

65
TITLE OF
ARTICLE

Estimation of
the Mismatch
between
Admission
and
Discharge
Diagnosis for
Respiratory
Patients, and
Implications
on the
Length of
Stay and
Hospital
Charges

AUTHOR
YEAR

Zikos, D.,
Shrestha, A.,
& Fegaras,
L. (2019)

RESEARCH
AIM
Search Terms
Database
Dates
Fit (PICOT)

Measure
discrepancy
between admit
and discharge
diagnosis, and
create a real
time program
to raise
awareness of
the need for
differentials
diagnosis
considerations,

Study Design
Type of Evidence
Level /Quality
Statistical
Analysis
c-stat
Limitations
with a unique
identifier
using
iCAPTURE Centre
database system
Two-tailed tests
SAS version 9.1
Limitations
Single-centre
retrospective study,
not designed or
powered to address
specific treatment
Quasi-experimental
II B

Population
Inclusion/Exclusion

OUTCOME
MEASURES/
RESULTS

RECOMMEN
DATIONS/IM
PLICATIONS

Times cited
Trust
Notes

Robust
differentials
must be
considered at
the time of
admit for
appropriate
careYes

Yes

readmission rates
and LOS

Medical claims data
for respiratory
conditions

Admitting and
discharge
diagnoses are
often mistaken –
up to 60%
leading to
increase LOS and
costs

66
Title

Author/Ye
ar

Research Aim
Type of
Population
Outcomes/
Recommendati Times cited
Search Terms
Evidence
Inclusion/
Results
ons or
Trust
Database
Level /Quality Exclusion
Implications
Notes
Dates
c-stat
for Study
Fit (PICOT)
Limitations
RISK PREDICTION MODELS (Optimal: algorithms with low-high stratification, real-time data, coding, concrete data available in HER, shared
data IP/OP)
Multimorbidity
in Risk
Stratification
Tools to Predict
Negative
Outcomes in
Adult
Population

AlonsoMorán et
al. (2015)

Summarize
validated risk
stratification tools
for predicting
negative outcomes,
with a specific
focus on
multimorbidity
COPD
readmissions
Risk stratification
Outcomes
Cochrane
NURS620
Search
2/2020
Fit – Yes,
Tied to
readmission PM
with variables

Trajectories of
Repeated
Readmissions
of Chronic
Disease
Patients: Risk
Stratification,
Profiling, and
Prediction

BenAssuli, O.
& Padman,
R. (2020)

Investigate
unplanned
readmission risk
within 30 days for
patients seen in
ED with multiple
chronic conditions
over time as a
heterogeneous
population and as

Systematic
review
Level III B
c-statistics 0.50.85 (highest
with disability)
Statistical
Analysis:
Data too
heterogeneous
to allow metaanalysis so
used
qualitative
synthesis (see
notes section)
Weakness:
limitations in
generalizability
due to variety
of risk factors
? Level III A
New Research/
Modeling
framework
Logistic
Regression and
Boosted
Decision Tree
using
Microsoft
AZURE ML

Review of 3,674
citations
36 articles met
inclusion criteria
Metanalysis with both
derivation and
validation cohorts
29 had as outcome
hospital
admission/readmissio
n.
Exclusions:
Psych, Post- surgical,
Peds and Developing
countries

Primary aim
multimorbidity
(primarily using
Charlson tool) and
validated tools for
risk prediction of
readmission
Results:
Risk PM with
multimorbidity (HF,
DM, Stroke, age and
disability) as
predictor variable
are more accurate

HMOs serving >4
million customers
De-identified data
extraction from
EHRs/ HIE from
471,192 topics
covering ED visits
from 2005-2008
Final models
clustered 16,117

Recommended
statistical methods
using STATA SAS
GBTM over CLCM
and HMM models
with dual statistical
and machine
learning
Successful
prediction of group
and individual

Cited - 20
Trust – Yes
Table of risk
stratification
tools
“ACG-PM”
heath care cost,
Use of SQLape
Logistic
Regression,
Probability of
Repeat
Admissions
(PRA)
Older study,
Did not analyze
newer tools

Important to
follow patients
over time to restratify risk due
to complexity
Information is
generalizable to
many scenarios
where repeated
information is
collected on

Trust – Yes
Finite mixture
models such as
GBTM, GMM,
CLCM aim to
identify and
profile small
volume latent
trajectories
grouping
individuals into
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Title

Big Data for
the
Stratification of
Readmission
Risk After
Hospital
Discharge of
Older Adults
with Complex
Conditions

Author/Ye
ar

He et al.
(4/2019)

Research Aim
Search Terms
Database
Dates
Fit (PICOT)
individuals with
specific risks
Investigate impact
over time of risk
factors
Explore PM for
trajectories on
future readmission
Readmission,
Risk stratification
Risk prediction
Business
Management
Hand Search
2/2020
Fit – Yes,
Readmission, Risk
stratification and
Prediction

Type of
Evidence
Level /Quality
c-stat
Limitations
Limitations:
Israel
HMO

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

patients into three
trajectory categories
100,286 ED visits and
34,651 readmissions
Inclusion/Exclusion
Multiple comorbidity
Chronic patients
followed over years

readmission
trajectories

individual
behaviors
Need studies on
non-chronic
and/or all
inpatient
admissions,
Software to
adapt to
digitization of
healthcare using
varying home
monitoring,
covariates,
social
determinants
Future to
include factors
from ED,
inpatient,
ambulatory, and
community

Develop a method
to stratify the risk
of readmission in
an older, frail and
high comorbid
population
Reference hand
search
3/202
Fit – Yes

Predictive
Prospective
Study
Level III C
Statistics
analysis with
machine
learning
models
including
Logistic

Consecutive
admissions to
subacute care unit Jan
2015 – April 2016
Inclusions/Exclusions
not identified

Trained different
machine learning
models: Logistic
regression, Support
vector machines,
Decision trees and
Random Forest
Results:
Random Forest gave
best stratification

Data supports
“cost-effective
action
plans”/focused
preventive
measures on
high-risk
patients

clusters to match
patient’s
evolving
characteristics
Used CCI and
LACE, age
Insurance
(HMOs), LOS,
Readmissions
and ED visits
Creat level
Persons living
with multiple
chronic disease
increasing (HHS,
2010)
Risk
stratification at
group level and
Risk prediction
at individual
level to assess
risk of future
readmission
Cited – none
found
Trust -Yes
Define “cost”
effective plans
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Title

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)
PMs for risk of
readmission for
focused preventive
care intervention

Risk Prediction
Models for
Hospital
Readmission: A
Systematic
Review

Kansagara
et al.
(2011)

Summary
validated
readmission risk
prediction models,
described their
performance, and
assess suitability
for clinical or
administrative use
COPD
readmissions
Risk stratification
Outcomes
Cochrane
NURS620
Search

Type of
Evidence
Level /Quality
c-stat
Limitations
regression,
Support
Vector,
Decision
Trees, Random
Forests
c-stat 0.63
Increased cstat to 0.8
adding prior
hospital
admits, LOS,
distinct
diagnostics
Limitations:
pending
original
study/requeste
d
Systematic
Review
Qualitative
Synthesis
Level III B
Limitations:
Cannot use
findings to
generalize.
Biases present
Studies too
heterogenous
to permit metaanalysis
Results
qualitatively

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

Review of 7,843
citations
30 studies of 26
unique models met
Inclusion criteria:
English,
Stat models to predict
hospital readmission
risk,
Dual cohorts derivation and
validation,
All cause readmission
Exclusions: Psych,
Surgical, Developing
nations

Primary outcome:
30-day readmission
but only 1 model
addressed
preventable
readmission
14 models could be
potentially used to
risk adjust for
readmissions
including
comorbidity, prior
medical service
2 studies found
functional and social

Innovations
needed to
collect broader
variables:
psychosocial
factors
Risk
stratification
effect on
“clinic’
workflow and
resource
prioritization
should be
assessed

Cited -960
Trust – Yes
Found
deficiencies in
risk prediction
models
2 studies used
social and
functional
variables
Define difference
prediction model
vs risk
stratification tool
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Title

Author/Ye
ar

Predictors of
30-day
Readmission
Among Patients
with AECOPD

Krishnan et
al.
(2019)

Predictors of
Early
Readmission
Among Patients
40-64 Years of
Age

Sharif et al.
(2014)

Research Aim
Search Terms
Database
Dates
Fit (PICOT)
2/2020
Fit – Yes, Risk
PMs with defined
risk factor
variables and
recommendations
for
intervention/resour
ces
Determine the 30day readmission
rate after
hospitalization for
COPD
exacerbation and
the predictors of
readmission
Searched
Article
ASP
2/2020
Fit – Yes,
Predictors of
readmission risk
for focused
interventions
Determine
frequency and
predictors of early
readmission for
patients 40-64 y/o
hospitalized with
COPD

Type of
Evidence
Level /Quality
c-stat
Limitations
synthesized
with focus on
model
discrimination
Poor
discrimination
c-stats .68-.83.
(improved w/
functional and
social
variables)
Nonexperiment
al
Quantitative
Retrospective
cohort
Level III
Grade B
Multivariate
Cox regression
analysis
Unable to
locate
study/Mendele
y not opening
for Limitations

Population
Inclusion/
Exclusion

Retrospective
cohort study
Level III B
c-stats
improved to
0.717 adding
provider and

Large national
database (8,263
patients) within 12
mo (Jan 2009 – Nov
2011) of the index
hospitalization and 30
days post discharge

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

Identify
multiple
independent
predictors of
readmissions
that can be used
to identify highrisk patients
who would
benefit the most
from
interventions

Cited - unknown
Trust – Yes
Unable to review
full text
Recent study
Very large
sample size
All cause and
COPD
Charlson
Socioeconomics

variables improved
discrimination
Results:
Measures of poor
health risk:
comorbidity, prior
use of medical
service and
increasing age
530,229 patients
National Readmission
Database 2016
Unable to locate
study/Mendeley not
opening for
Inclusions/Exclusions

Readmission rates
16.3% (All-cause)
and 5.4% (COPD).
Independent
predictors of
readmission: leaving
AMA, treatment at
high volume
centers, high
Charlson, low
income, urban
teaching centers,
male, Medicaid
insurance, younger
age, large hospital
bed size, and
prolonged LOS
Primary outcome:
All-cause 30-day
readmission (8%)
Secondary outcome:
reasons for and
factors associated
with readmission

Cited – 74
Trust – yes
Provider and
system factors
often unknown at
time of index
admission

70
Title

Hospitalized
for COPD

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)
Reference hand
search
3/2020
Fit – Yes,
Tied to
readmission and
modifiable risks

Type of
Evidence
Level /Quality
c-stat
Limitations
system factors
to patient
factors (alone
c-stat 0.677)
Descriptive
statistics with
Chi-squared
for
readmission
rates across
category levels
and
Student t tests
for continuous
variables
Multivariate
logistic
regression
models
SAS 9.2
Limitations:
ICD9
(including 490,
493)/coding,
No info on
disease
severity or
complexity of
index
admission, not
generalizable
as age studied
was 40-64, no
socioeconomic or

Population
Inclusion/
Exclusion

Outcomes/
Results

Inclusion:
Commercial
insurance,
Age 40-64,
Hospitalized with
primary Dx COPD
Excluded:
Medicare/caid

(Patient – male,
comorbidities HF,
CA, OP,
Depression;
Provider – no Rx
prior statins, and no
discharge SABA,
steroid, or
antibiotic; and
System – LOS<2d
or >5d, lack of
follow up after
discharge)
Results:
Provider and system
factors are important
modifiable factors in
early readmission

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes
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Title

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)

Type of
Evidence
Level /Quality
c-stat
Limitations
adherence
information

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

Reducing
COPD
Readmissions
Through
Predictive
Modeling and
IncentiveBased
Interventions

Zhong et
al. (2019)

Develop an
optimization
model to support
decision making
during
interventions to
reduce
readmission rate
and cost
2/2020
Fit- Yes,
Predictive
Modeling for highrisk stratification

? Level III A
New Research/
Modeling
framework:
risk factor and
level of risk
prediction
model and
intervention
model
Odds ratios for
categorical
data
Chi-square for
contingency
tables
Limitations:
limited data,
Only high-risk
patients but did
not consider
heterogeneity
in the
subgroup,
Interventions
available/not
available,
Health
behaviors – it
is unknown if
incentive(s)

Physician and staff
interviews
All patients with
COPD from hospital
database, 114 of 134
had admission
records, 24 patients
readmitted within 30
days (rate 21%)

24 variable risk
factors identified
Limited size with
missing values
could not reach
significance for
readmissions
dependent to
variables
Intervention flow
model using
mathematical
formulas to
determine cost
incentives for
interventions
(Rehab, PCP follow
up, both or none) to
reduce readmissions
or accept agreed %
loss for highest risk
patients

Investigate the
impact of
patient
compliance on
readmission
probability.
Results could
serve as
guidelines or
best outcomes
to help hospitals
determine/cap
budget for
patient-centered
incentives,
appropriate
level of
incentive and
resources
Partner with
insurance and
other facilities
for shared
costs/value to
incentive
planning
Community
hospital pilot
pending

Trust – Yes
Innovative
model:
What is the
minimal
investment/incen
tive to commit to
a high-risk
patient and how
much of a
decrease in
readmission can
be accepted?
Define what is
the goal % for
readmission

Inclusion/Exclusion
not identified

72
Title

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)

Type of
Population
Outcomes/
Recommendati Times cited
Evidence
Inclusion/
Results
ons or
Trust
Level /Quality Exclusion
Implications
Notes
c-stat
for Study
Limitations
modify
behaviors,
Limited study
to
readmissions
as opposed to
other outcomes
RISK STRATIFICATION TOOLS (Optimal: c-statistic, validated, clinical setting use, comorbidity, and psychosocial-economic factors)

A New Method
of Classifying
Prognostic
Comorbidity in
Longitudinal
Studies:
Development
and Validation

Charlson et
al. (1987)

Develop
prognostic
taxonomy for
comorbid
conditions that
may alter risk of
short-term
mortality
Reference hand
search
3/2020
Fit – Yes,
Readmission tool
using comorbidity

? Level III B
Hallmark study
of the
prognostic
impact of
comorbidity
Statistical
Analysis
Chi-square test
calculated by
log rank
method,
Cox’s
regression
using PHGLM
procedure (like
SAS), scoring
system using
Hutchinson
and Thomas
method,
relative risk
from
proportional
hazards model,

Sample with
inclusion/exclusion:
Derivation cohort (all
patients admitted to a
medical services) 604
patients x1 mo in
1984 in NY hospital
Followed one-year
mortality
Then 685 patients
treated for breast CA
at Yale Hospital
between 1962 and
1969

Develop
comorbidity index
One-year mortality
rates significantly
worse with CA and
AIDS; liver disease,
paralysis
The major
differences were
between pts w/o
comorbidity and
those with 1+
2 predictors of
morbidity: age and
comorbidity (every
10 years of aging
was equivalent to 1
comorbidity)

Classify patients
with
comorbidity
index to reduce
restrictive
eligibility
criteria during
studies
Patients at
greater risk can
be evaluated or
randomized
separately

Cited – 24.9K
Trust -Yes
Older hallmark
study, need to
review multiple
times
Comorbidity
study only
Mortality study

73
Title

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)

Original Study
for ERA:
Use of An
Electronic
Administrative
Database to
Identify Older
Community
Dwelling
Adults at High
Risk for
Hospitalization
or ED visits:

Crane et al.
(2010)

Goal: demonstrate
the use of an
electronic EMR to
create an
administrative
index which is
able to risk-stratify
this heterogeneous
population
Hand search
3/20202
Fit- Yes, Risk
stratification tool

Type of
Evidence
Level /Quality
c-stat
Limitations
Survival and
staging curves
for the testing
population
using Kaplan
and Feinstein
Methods
Limitations
Power may
have been
underestimated
due to deaths
and /or how
deaths defined,
relatively small
n,
Validated
weighted index
but
comorbidityage composite
not validated
Retrospective
cohort
Score
evaluated for
sensitivity and
specificity
Level III B
c-stat not
found
Limitations:
Low response
rates (50-60%),
Recall bias,

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

12,650 communitydwelling and assisted
living adults >60 y/o
assigned to internal
med PCP Jan 1, 2005
Excluded:
SNF
Information
electronically
abstracted
Look risk factors over
the previous two
years:

Primary outcome:
Total number of ED
visits and
hospitalizations
Results:
Patients in the
highest 10% risk
group (included all
comorbid
conditions) had a
relative risk of 9.5
for ED or
hospitalization year

Useful for
managed care
setting but
challenging to
adopt in fee-forservice due to
limited access to
various data
bases

Cited – 72
Trust -Yes
What if age <60
with comorbidity
ERA performed
better than
Probability of
Repeated
Admission
(PRA) and
Community
Assessment Risk
Screen (CARS)

74
Title

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)

The Elders
Risk
Assessment
Index

International
Validity of the
“HOSPITAL”
Score to Predict
30-day
Potentially
Avoidable
Readmissions
in Medical
Patients

Donze et
al. (2016)

Externally validate
HOSPITAL score,
internationally,
multicenter
Reference hand
search
3/2020
Fit – Yes, risk
stratification tool
for 30-day
readmission
avoidable
readmissions

Type of
Evidence
Level /Quality
c-stat
Limitations
Literacy,
Time,
Cost,
Coding,
Retrospective,
External care
may have
occurred w/o
knowing,
No functional
status measure
(difficult to
have data w/o
interview or
objective
measure)
Retrospective
cohort
Level III A/ B
Statistical
Analysis:
Pearson
goodness to fit,
Proportions,
means, and
medians with
IQR, twosided, Brier
score and
Logistic
regression
c-stat 0.72
SAS 9.3
Limitations: all
medical so not

Population
Inclusion/
Exclusion

Outcomes/
Results

Demographics,
Comorbidities (DM,
CAD, HF, stroke,
COPD, Hx CA, Hx
hip fracture,
dementia) and
Hospitalizations

one and relative risk
13.3 for
hospitalization in
subsequent year

9 hospitals in 4
countries
Jan-Dec 2011
117,065 patients
Inclusions:
All adult patients
from medical
department,
LOS >1 day
Exclusions: Transfers,
AMA

Primary outcome:
Identify all 30 day
potentially
avoidable
readmissions and
then validated using
SQLape algorithm
“HOSPITAL”
identified high risk
30 day potentially
avoidable
readmissions

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes
Retrospective
only
No c-stat found

Use of the score
can easily ID
patients in need
of intensive
transitional
care; however,
the variables are
predictors and
not necessarily
modifiable risk
factors so the
variables cannot
be used to guide
interventions

Cited – 72
Trust – yes
Medical patients,
non-specific to
COPD and
inclusive of
oncology
Dependent on
lab
Most effective
interventions
high complexity
(Naylor et al.,
1999 RCT)

75
Title

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)

The PEARL
Score Predicts
90-day
Readmission or
Death after
Hospitalization
for AECOPD

Echevarria
et al.
(2017)

Tool to 1) predict
90-day
readmission or
death without
readmission and 2)
assess
performance at 30
days and compare
the new tool with
other prognostic
scores.
Developed in two
hospitals (the
derivation cohort)
and validated in:
(a) the same

Type of
Evidence
Level /Quality
c-stat
Limitations
generalizable,
additional
variable of
functional and
socioeconomic
status, 30 day
may not be
appropriate
time frame,
delays in
ability to score
if data not
available
(transitional
are is best if
started early),
labs may
change by time
of discharge
Quantitative
Quasiexperimental
Prospective
Internal and
External
Validation
Level II B
Cohorts pooled
for weighting
/re-weighting
levels
CI appropriate,
SPSS and
Sigma
Plot/Rubin’s,

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

2,417 patients in the
UK
Inclusions: Primary
Dx COPD,
Spiro,
Age>35,
Smoking Hx
Exclusions: Terminal
illness limiting
survival <1 year,
Prior inclusion in
same cohort

Primary outcome:
Validate tool for 90day readmission to
cover high-risk
period.
Secondary outcome:
Assess tool
performance at 30
days
The PEARL score
was consistently
discriminative and
accurate.
Higher PEARL
scores were
associated with a

The PEARL
score is a simple
tool, superior to
others,
effectively
stratifies
patients' risk of
30-90-day
readmission or
death, which
could help guide
readmission
avoidance
strategies within
the clinical and
research setting

Cited - 24
Trust -Yes
Superior to
ADO,
BODEX,
CODEX, DOSE,
LACE
COPD specific
but includes
comorbidity with
high impact,
Levels of risk,
Accounts for
factors
associated with
higher predictive
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Title

Validation of
the DECAF
Score to Predict
Hospital

Author/Ye
ar

Echevarria
et al.
(2016)

Research Aim
Search Terms
Database
Dates
Fit (PICOT)
hospitals later
(internal validation
cohort) and (b)
four further UK
hospitals (external
validation cohort)
COPD
readmissions
Risk stratification
CINAHL,
Medline+
NURS620
Search 2/2020
Fit- Yes, Risk
stratification tool

Validate the
DECAF score,
internally and
externally, and

Type of
Evidence
Level /Quality
c-stat
Limitations
ROC, logistic
regression,
HosmerLemeshow
goodness to fit,
Kaplan-Meier
and log rank
test
c-statistic of
0.73, 0.68 and
0.70 in the
derivation,
internal
validation, and
external
validation
cohorts
Limitations:
Different
country
Retrospective
bias but
external cohort
was
prospective
and
individually
powered
Researchers
blind to
outcome
Quantitative
Nonexperiment
al Prospective
Internal and

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

shorter time to
readmission

1,725 patients
2 UK hospitals
(internal validation)
and 4 UK hospitals

Primary outcome:
in-hospital mortality
prediction

Times cited
Trust
Notes
model
recommendation
s
Application to
outpatient
Simple tool
Outperforms:
BODE
LACE
CODE
ADO
DOSE

It can identify
low-risk
patients for
HAH or early

Cited – 33
Trust – Yes
Mortality study

77
Title

Author/Ye
ar

Mortality in
Exacerbations
of COPD

Research Aim
Search Terms
Database
Dates
Fit (PICOT)
compare
performance to
other predictive
tools
Reference hand
search
3/2020
Fit – Yes,
predictive tool for
COPD mortality
and risk
stratification

Readmission
After COPD
Exacerbation
Scale:
Determining
30-day
Readmission
Risk for COPD
Patients.

Lau et al.
(2017)

Develop a
predictive
readmission scale
to identify COPD
only patients at
higher readmission
risk
COPD
Hospital admission
Risk stratification
Google Scholar
NURS620
Search
2/2020
Fit- Yes, Risk
stratification tool

Type of
Evidence
Level /Quality
c-stat
Limitations
External
Validation
Level III B
Prognostic
value
determined
using AUROC
curve
c-stat 0.77
Generalizable
Main
limitation:
Internal
validation was
in part
retrospective
Nonexperiment
al Quantitative
Retrospective
Level III B
Chi square,
univariate and
multivariate
analysis,
binary logistics
regression.
c-stat not
found
SAS software
Limited by
retrospective
design,
generalization,
possible
coding, and

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

(external validation)
between Jan 2012 and
May 2014
Inclusions: primary
diagnosis AECOPD,
Prior Spiro,
Age >35,
Smoking Hx >10
pack-years
Exclusions:
Survivability <1 year

Secondary outcome:
assessment of
optimal thresholds
for pH and
eosinpenia,
prediction of 30-day
mortality
Robust predictor of
mortality

discharge and
high-risk
patients for
escalating care
plans or early
palliative care

Dependent on
lab
eMRCD
strongest
predictor
Superior to
APACHE II,
BAP-65, CAPS,
CURB-65

339,389 patients NY
and CA (derivation
cohort) and 258,113
patients WA and FL
(validation cohort).
Data abstracted from
State Inpatient
Database (2006–
2011), and the
Readmission After
COPD Exacerbation
(RACE) Scale was
developed to predict
30-day readmission
risk
Excluded
readmissions for
reasons other than
COPD

Endpoint: 30-day
readmission for
COPD and overall
IP mortality
COPD readmission
rates 6-7%. Factors
were age 40–65;
male; African
American; income;
Medicaid and
Medicare; anemia;
CHF; depression;
drug abuse;
psychoses
independently
associated w/
readmissions
Results:RACE scale
explained 92.3% of

Patient-specific
readmissionreduction
strategies can be
implemented to
improve patient
care, reduce
readmissions
and healthcare
expenditure

Cited - 7
Trust – Yes
Inpatient study
Older age was
not scored and
yet majority over
65 and at higher
risk
Retrospective
study

78
Title

Evaluation of a
Modified
BOOST Tool
in the Acute
Care Setting: A
Retrospective
Analysis
*Original study
2009:
Project BOOST
Seeks to
Improve Care
Transitions

Author/Ye
ar

Robertson
(2017)
Original
authors:
Society of
Hospital
Medicine
(2009)

Research Aim
Search Terms
Database
Dates
Fit (PICOT)

Evaluate the
effectiveness of
the modified 8P
risk tool predicting
unplanned 30-day
readmission in
patients with heart
failure and COPD
COPD,
Readmission
Risk stratification
CINAHL,
Medline+
NURS620
Search
2/2020
Fit- Yes, risk
stratification tool

Type of
Evidence
Level /Quality
c-stat
Limitations
sampling
errors and
possibly
underestimated
Nonexperime
ntal
Quantitative
Retrospective
Or Quasiexperimental
as subset of
population was
randomized
Level III B
Statistical
Analysis:
Contingency
tables compare
risk scores.
Adjusted
residuals
calculated for
significance
between
groups. Chi
sq., Binomial
logistic
regression
c-stat n/a
SPSS 14.0
Limitations:
Lacking
validity on
prediction.

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

The modified
tool may assist
in predicting the
risk of
readmission
Further study
needed for other
risks e.g., is
there a
difference in
readmission w/
home health
care, early
follow-up,
transition
programs

Cited X 1;
Trust –Yes
Hospitalist focus
Reference #18
Advisory Board
reported several
readmission tools
and found
statistically
significant
readmission
reduction using
BOOST
Original
BOOST: Better
Outcomes by
Optimizing Safe
Transitions
The risk factors
of depression,
health literacy,
support, and
engagement w/
PCP were not
significant for
readmission in
this study.

readmission
variability
All patients (356)
with HF or COPD
discharged Dec 2013
-Nov 2014.
Exclusion:
Incomplete risk
assessment during
admission
Data from EMR.
Demographic:
diagnosis, age, sex,
marital status, and
insurance

Modified goal:
Evaluate
effectiveness of a
modified version of
the tool for HF and
COPD
Modified BOOST 8
risk factors: problem
medications,
polypharmacy,
depression
screening, principal
diagnoses, health
literacy, patient
support (single),
prior hospitalization,
and primary care
provider
Higher readmits for
medications,
polypharmacy, and
problem diagnoses,
women, single
status
Original primary
goals: Develop a
tool screening kit to
reduce 30-day
readmission rates
for general medical

79
Title

Which
Readmissions
May be
Preventable?
Lessons
Learned from a
Posthospitalizat
ion Care
Transitions
Program for
High-risk
Elders

Author/Ye
ar

McCoy et
al. (2018)

Research Aim
Search Terms
Database
Dates
Fit (PICOT)

Evaluate effects of
the Mayo Clinic
Care Transitions
(MCCTs).
Program on
potentially
preventable and
nonpreventable
30-day unplanned
readmissions
among high-risk
elders
COPD
Hospital admission
Risk stratification
RCT

Type of
Evidence
Level /Quality
c-stat
Limitations
Small sample
for subgroup
analysis.
Not
generalizable

Population
Inclusion/
Exclusion

Retrospective
cohort study
and propensity
score-matched
controls
receiving usual
primary care
Level II B
c-stat n/a
t-tests,
Wilcoxon rank
sum, chi sq.,
ordinal and
skewed
continuous,
nominal,
Fishers,

365 pairs of MCCT
enrollees
primary care, 60 years
or older (mean 83),
high ERA score, live
independent, in
specific geo area,
hospitalized for any
cause between Jan
2011 and June 2013
Similar demographics
and clinic
characteristic
Exclusions: Cancer,
End of
life/palliative/hospice,
HIV,

Outcomes/
Results

patients with
interventions:
Improve patient
satisfaction,
Improve H-CAHPS,
Improve flow of
information between
hospitals and
outpatient,
Ensure high-risk
patients identified
for specific
interventions,
Improve patient and
family education
using teach-back
process to riskspecific issues
Primary outcome:
Rate of 30-day all
cause hospital
readmissions among
patients enrolled in
MCCT compared to
matched controls
Used ERA (Elder
Risk Assessment
Tool)
Results:
MCCT enrollees
had significantly
lower
potentially
preventable

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

MCCT
significantly
reduces
preventable
readmissions,
suggesting that
access to
multidisciplinar
y care can
reduce
readmissions
and improve
outcomes for
high-risk elders

Cited - 1
Trusted – Yes
Combination of
stratification
tools: ERA
(older patients
only) and
Charlson
NP home visits
Question:
how was highrisk determined

80
Title

Clinical
Validation of a
Risk Scale for
Serious
Outcomes
Among Patients
with COPD
Managed in the
Emergency
Department.

Author/Ye
ar

Stiell et al.
(December
03, 2018)

Research Aim
Search Terms
Database
Dates
Fit (PICOT)
Google Scholar
NURS620
Search
2/2020
Fit- Yes, Risk
stratification tool

Validate,
prospectively and
explicitly, the
OCRS when
applied in ED by
physicians.
Ottawa COPD
Risk Scale
(OCRS), 10
criteria, was
previously derived
in ED with COPD
at high risk for
short-term serious
outcomes
COPD
Hospital admission
Risk stratification
RCT
Google Scholar

Type of
Evidence
Level /Quality
c-stat
Limitations
Kaplan Meier,
Cox PH model
Limitations:
Not powered
for each
category
computer
algorithm
possible
misclassificatio
n
lack of
generalizability
due to
population
Nonexperiment
al
Quantitative
Prospective
cohort
Level III C
Statistical
Analysis:
Criterion
interpretation,
calculated
sensitivity and
specificity with
95% CIs,
admission
proportion
Limitations:
Population
selection may

Population
Inclusion/
Exclusion

Outcomes/
Results

AMA

readmissions,
reduced by 44%
3M algorithm
identified
potentially
preventable
readmissions and
subset of
ambulatory care
preventable
readmissions

6 tertiary care
hospitals, adults with
AECOPD from May
2011 to December
2013. 1415 patients
with a mean age of
70.6 (SD 10.6) years
and 50.2% were
female.
Monitored 30 days
for short-term serious
outcomes of death,
admit to monitored
unit, intubation, NIV,
MI, readmission
occurred in 135
(9.5%) cases
Inclusion
Consecutive eligible
adults age >50 with

Primary outcome:
validate
prospectively the
OCRS for its
accuracy in
predicting shortterm serious
outcomes
Secondary outcome:
Document
acceptability with
clinicians and its
potential effect on
patient safety and
hospital admissions
Results:
Our study allowed
physicians to apply
the OCRS explicitly

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

This risk scale
can now be used
to help ED
disposition
decisions for
patients with
COPD, which
should lead to a
decrease in
unnecessary
admissions and
in unsafe
discharges

Cited - 6
Trust - Yes
Different country
ED application
AECOPD
defined
May have
application to
UC or acute
clinic visits

81
Title

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)
NURS620
Search
2/2020
Fit- Yes, risk
stratification tool

Type of
Evidence
Level /Quality
c-stat
Limitations
be biased,
unable to
generalize

Population
Inclusion/
Exclusion

Outcomes/
Results

AECOPD considered
well enough for
discharge
Exclusion:
Extremely ill after 2
to 12 hours of ED
management,
confusion,
disorientation, or
dementia; chest pain,
acute ischemic ST–T,
death expected within
weeks from chronic
illness, long-term– or
chronic-care facility;
long-term
hemodialysis,
enrolled in the study
in the previous 2
months

in real-time for
patients AECOPD
OCRS showed
better sensitivity for
short-term serious
outcomes compared
with current practice

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

INTERVENTIONS:
Clinical – Access to care, GBT, health coaching/MI, comprehensive care, care transitions, integrated care, patient education/action plan
Patient – Risk factors, self-management/self-monitor
MULTIPLE INTERVENTIONS
Health
1. Benzo et
To determine the
RCT Level 1A 215 patients
Primary endpoint
Health coaching Trust – Yes
Coaching and
al. (2016)
effect of
Statistical
hospitalized with
COPD related
feasible and
Mayo and Health
COPD
comprehensive
analysis
AECOPD received
hospitalization 12
possible
Partners study
Rehospitalizati
health coaching on compared two
either MI health
mos. with secondary effective
on
the rate of COPD
treatment
coaching plus written endpoints 1, 3, 6
intervention to
readmissions
groups using
action plan for
mos.
reduce COPD
X2 tests, twoAECOPD and
Improved
readmissions
sided z-test
exercise advice or
QOL/CRDQ.
Analyses SAS
usual care with 1 year No differences in
version 9.4
follow up
physical activity
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Title

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)
To provide
updated clinic
aspects of COPD

Type of
Evidence
Level /Quality
c-stat
Limitations
Expert Opinion
Review V B

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

Update on
2.
Clinical
Aspects of
COPD
Promises and 3.
Perils of
Telehealth in
the Current
Erra

Celli, B. &
Wedzicha,
J. (2019)

COPD

Considerations for
GBT

Yes

Mahtta et
al. (2021)

To provide insight
for merit and
failings of
telehealth

Health Policy
Contemporary
Review V A

Telehealth services

PrietoCenturion
et al.
(2014)

Report results of a
systematic review
of RCT evaluating
interventions to
decrease
rehospitalizations
after AECOPD
Databases
included in the
review:
Google Scholar,
Web of Science,
PubMed,
EMBASE,
CINAHL,
Cochrane

Systematic
Review of
RCT
Level 1 C
Statistical
Analysis
c-stat
because of
heterogeneity
of
interventions,
measures,
outcomes, used
narrative
synthesis as
opposed to
meta-analysis
Limitations
Heterogeneity,

Multiple databases
searched Jan 1966June 2013
913 titles and
abstracts screened; 5
studies (1,393
participants) met
eligibility criteria
Inclusion criteria:
Search words and
terms were identified.
English language,
RCT,
COPD patients,
Hospitalization within
the prior 12 months,
Primary outcome
rehospitalization
Exclusion if solo
focus:

Cost-effective,
improves access and
timely care, match
supply and demand
however
Potential to widen
disparities if used
inappropriately, may
increase costs if
overused, and
cybersecurity threats
Primary outcome of
all studies:
rehospitalization at
6-12 months.
No study examined
30-day
rehospitalization
Interventions
classified into three
categories:
1.predischarge,
2.postdischarge,
3.bridging spanned
pre- and postdischarge

Think of COPD
as a syndrome
rather than a
single disease
Post-pandemic
telehealth policy

Interventions to
4.
Reduce
Rehospitalizati
ons After
COPD
Exacerbations

Evidence base
inadequate to
recommend
specific
interventions to
decrease
rehospitalization
s after
AECOPD
Caution when
implementing
programs given
heterogeneity
and risk of
death in one
study, presence
of comorbidity
will be
inefficient and
burdensome.

Cited – 58
Only U.S. study
(Fan et al, 2012)
showed higher
risk mortality in
the intervention
group at VA
centers using
comprehensive
care (unclear
which
intervention was
effective or
harmful)
Requested Fan
study from
Interlibrary loan
4/28/2020
Cited BOOST
with caveat to

Yes
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Title

COPD
5.
Readmissions:
Addressing
COPD in the
era of ValueBased Health
Care

Author/Ye
ar

Shah et al.
(2016)

Research Aim
Search Terms
Database
Dates
Fit (PICOT)

Summarize current
challenges and
knowledge about
AECOPD
readmits, inform
ongoing work to
improve care
quality, reduce

Type of
Evidence
Level /Quality
c-stat
Limitations
Possibly
missed
identifying an
intervention,
did not include
pharm studies,
limitations in
understanding
study designs

Population
Inclusion/
Exclusion

Literature
Review
Level V B/C
Statistical
Analysis brief
points of
discussion:

Identified risk factors
for early readmissions
after AECOPD and
discusses tested and
emerging strategies to
reduce these
readmissions

Outcomes/
Results

Decrease LOS,
Pharmacology,
Procedures,
Technology-base,
Pulmonary Rehab

Variables in coding
– provider, biller
and location,
Defining and caring
for “preventable”
and “all cause”
readmissions

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

Rather focus on
care
coordination in
ambulatory
setting and
address
socioeconomics
supplemented
with GBT
Variable content
of 1.
interventions
and context e.g.,
home visit
topics, number
and timing of
visits),
2.
measurements
e.g., selfreports, EMR
review,
reporting,
3.inconsistent
patient reports
for
socioeconomics
Consensus to
define
AECOPD
ICD9-10
provider or
biller,
Real time data,

add EBP
modules for
AECOPD

Cited - 42
Trust – Yes
Frailty: look at
size not strength
of quad and
speed not
duration of walk

84
Title

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)
readmissions after
AECOPD
Reference hand

search
3/2020
Fit-Yes,
considerations
for definitions
and
interventions
for AECOPD
with
readmissions

Type of
Evidence
Level /Quality
c-stat
Limitations
Cochrane
review risk
ratio 0.77,
c-stat varied
0.71-0.82
Limitations
Not id’d

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

Evaluate the current
HRRP and future
policy change
Inclusion
Defining AECOPD,
Coding,
Risk Prediction
including
comorbidity,
Self-management and
education with teachback,
PR,
Telehealth,
Medications,
Financial constraints
Comprehensive care
management,
/Exclusion

Variances in health
care system
readmission policies
(public/private,
urban/rural) and
availability of
diagnostic measures
and interventions
Telehealth
demonstrated
decrease in ED and
hospital admits over
1 year
High risk factors
defined: frailty, HF,
DM, renal failure,
psych conditions,
drug and alcohol
use, disease
severity/breathlessn
ess, low BMI,
discharge to postacute care, >LOS,
Medicare/caid,
possible male and
black race
Interventions Table
and
Variable success of
interventions
shifting focus on
large network
collaboratives

Ability to
predict and
identify highrisk patients
especially
vulnerable
patients,
identify
programs to
improve clinical
efficacy and
reduce costs and
address
policy issues
such as
reimbursement
to the
community in
value-based
care
Re-evaluation
of the home as
an ideal setting
for AECOPD
treatment

Great summary
and
considerations
1/3 patients
readmitted in the
first week of
discharge by
PCP,
pulmonologist or
practitioner-led
home visit
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Title

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)

Type of
Evidence
Level /Quality
c-stat
Limitations

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

Level V B
SPSS software,
Pearson’s chisquare
Limitations:
Small sample,
Limited data
collection
period,
Unable to
generalize

Patients discharged to
home with primary
Dx COPD between
Jan 2017-May 2017.
Exclusion:
No primary Dx
COPD,
Discharged to SNF
Used LACE:
LOS, Acuity of
Admission,
Comorbidity, ED
services

Gaps: inconsistent
Rx, Rx
nonadherence,
inconsistent postdischarge follow-up,
specialty follow-up
inconsistent
Findings associated
with higher readmit:
Selfmanagement/nonadherence,
Rx concerns,
Younger age on
public insurance,
>LOS,
Comorbidity,
GBT/flu vac and
symptom control,
APP or MD
acceptable,
Nursing and RT
important

Risk
stratification
critical,
ID risk factors
important and
More research
needed on
economic
impact of
interventions

Cited - 0
Some older
studies included
for discussion
Unknowns
interdisciplinary
and bundled
programs

SELF-MANAGEMENT/ADHERENCE

PostHospitalization
Management of
Patients with
COPD

Blaha et al.
(2018)

Aim papers
reviewed b/n 2016
and 2017 for
economics of
interventions post
HRRP
CHECK: QI
improvement
project using
transitions theory
to better
understand factors
influencing COPD
readmissions,
analysis of nursing
specific
interventions, postacute care followup and targeted
medical
interventions
Fit – Yes,
interventions for
managing COPD

TRANSITIONAL CARE
Broad range of services and environments designed to promote the safe and timely passage of patients between levels of healthcare and across care
settings; improve “handoff” of patients and their family caregivers

86
Title

Author/Ye
ar

Models of Care
6.
Across the
Continuum of
Exacerbation
for Patients
with COPD

Bourbeau
&
Echevarria
(2019)

Readmissions 7.
for COPD,
2008

Elixhauser,
A., Au, D.,
Podulka, J.
(2011)

Research Aim
Search Terms
Database
Dates
Fit (PICOT)
Approaches of
care and outcomes
of interest
including hospital
readmissions,
mortality, health
status and costeffectiveness
Search
Article
ASP PubMed
2/2020
Fit – Yes, models
of care for COPD
to reduce
readmissions,
mortality, and
costs

Type of
Evidence
Level /Quality
c-stat
Limitations
Narrative
Review
Level V A
Statistical
Analysis
Machine
learning use of
computations
of past
information to
improve
performance or
make accurate
predictions
(validation
studies
pending in
real-life
scenarios)
Limitation:
Expert
understanding
with
foundation of
evidence for
model of care.
However,
different
country.

High and variable
rates of
readmissions may
indicate
suboptimal

Statistical
Brief
Level V A

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

Different models of
care across the
continuum of
exacerbations (1)
chronic care and selfmanagement
interventions with the
action plan, (2)
domiciliary care
(RCT) for severe
exacerbation and the
impact
on readmission preve
ntion and (3) the
discharge care bundle
(variable evidence)
for AECOPD
management
Inclusion/Exclusion
AECOPD
Chronic care and selfmanagement with
action plans (cost
savings),
Domiciliary care
including HAH
criteria (cost savings),
Discharge care bundle
(insufficient
evidence)
COPD
15 states,
190,700 admissions

COPD bundles may
also improve the
transition of care
from the hospital to
the community
following
exacerbation and
may
reduce readmission r
ates
Model of Care
Based on prior cost
savings and RCT

Future models
should be
personalized
and adaptable to
the patient
situation,
severity of
disease,
comorbidity,
access to health
care
Identify patient
needs,
preferences,
goals to design
the care plan
Focus on
improved
communication,
co-morbidities,
social
determinants,
patient
education, selfmanagement,
quality of care,
risk
stratification
and risk factor
identification
Quality care
including
Transitional
care

Cited - 1
Trust – Yes
Cited DECAF to
id low-risk
patients in the
hospital that may
be appropriate
instead for HAH
Defines selfmanagement
intervention well

Presented data
regarding hospital
readmissions within
30 days

Yes
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Title

Author/Ye
ar

Nurse
8.
practitioner-led
transitional care
interventions:
An integrative
review

Mora et al.
(2017)

Research Aim
Search Terms
Database
Dates
Fit (PICOT)
management of
patients following
hospital discharge
Synthesize
literature related to
NP-led transitional
care interventions
aimed at reducing
hospital
readmission
among
communitydwelling adults
>65 years of age
Analyze the
research question:
In communitydwelling adults
>65, can NP-led
intervention vs
standard care
affect hospital
readmissions
Google Scholar
2/2020
Fit – Yes,
intervention to
decrease
preventable
readmissions
within 30 days

Type of
Evidence
Level /Quality
c-stat
Limitations

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

Literature
Review

Patients with multiple
comorbidities
8 studies in a variety
of international health
care settings, 11,085
patients, mean age
73.9
Inclusion:
Focus on randomized
control trials (RTCs)
containing NP-led
TCM interventions
with older adults

No standard
intervention
NPs follow patient
daily IP identify
Goals,
Action Plan, Rxs
and Communication
Results:
Phone calls (e.g.,
within 72 hrs after
discharge and
available by phone
prn x90 days),
Home visits (e.g.,
home within 24 hrs
of discharge then
weekly x4 then
biweekly x4) by
NPs decrease
hospital
readmissions but
only intermittently
statistically
significant

Use of
theoretical
framework to
guide care
Standardized
procedure and
documentation
protocol
(checklist) for
assessments and
parameters to
guide home
visits and phone
calls by NPs

Trust – Yes
Cited x 17

Level V A
Statistical
Analysis/
Synthesis of
three RTCs,
one metaanalysis, and
four
nonrandomized
studies
reviewed TCM
intervention
Limitation:
APN specialty
not specified,
Interventions
initiated in
hospital,
Variable study
designs make it
difficult to
determine if
decline in
readmissions
directly related
to NP
interventions,
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Title

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)

Type of
Evidence
Level /Quality
c-stat
Limitations
Lack of
distinction
between nurse
and NP,
HMO,
Each patient
did not receive
the intended
intervention

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

COMPREHENSIVE CARE STUDIES
Provide personal health services for diagnosis, treatment, follow-up, and rehabilitation of patients and aims to offer personalized treatment to suit
individual needs. Comprehensive care consists of self-management and pulmonary rehabilitation and involves multiple healthcare providers
working together closely to provide formal structured programs for patients
Development
Benzo et
Aim to increase
Quasi
12 weekly sessions to Pilot selfImproved QOL, Trust -Yes
and feasibility
al. (2013)
patient
prospective
train registered nurse
management
fit and patient
Mayo and Health
of a COPD
engagement and
randomized
and respiratory
intervention
acceptability of
Partners
selfcommitment to
pilot
therapist using MI
including
selfmanagement
improve selfwith 44 patients (544
motivational
management
intervention
management with
encounters)
interviewing to
intervention
delivered with
overarching goal
guide patient,
motivational
to reduce COPD
increase patient
interviewing
related
engagement and
strategies
hospitalizations
commitment to selfmanagement with
goal to reduce
readmissions in
COPD patients,
produced no harm
and improved
patient satisfaction
and selfmanagement
primarily through
use of written action
plan and patient
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Title

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)

Type of
Evidence
Level /Quality
c-stat
Limitations

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

The
multidisciplinar
y care teams
needed to
support these
care models
pose expense to
the health-care
system
Little is known
about which
patients benefit
most from
specialist care.
One approach to
consider is to
identify patients
at highest risk
using prediction
tools for COPD
and HF
In the context of
an ACO, or
bundled
payments,
financial
incentives align
well with teambased integrated
care delivery
model

Cited - 2
Trust –Yes
Effective process
of care
interventions or
bundles of care
interventions that
scale reliably
across practice
settings and
health-care
systems have yet
to be described
for either HF or
COPD
Quality
references to
research

engagement (Benzo
et al., 2013)
Reducing
Readmission in
Heart Failure
and COPD

Kalhan, R.,
&
Mutharaso
n, R.
(2018)

Present 10
practical tips to
reduce readmissio
ns in this
challenging
population
Search
Article
WorldCat
2/2020
Fit - Yes

Gray Lit
Level V B
Expert report
but limited
discussion
comparative to
degree of
literature not
cited
Statistical
Analysis – n/a
Limitations
Consider
practical
practice
considerations
for reducing
readmissions,
but emphasize
that these
recommendatio
ns are not
robustly
evidence based

Tips in Practice
Management
Inclusion/Exclusion
COPD and HF

“Map” Diagnose
accurately, detect
AECOPD early, risk
stratification,
specialist
management,
modify underlying
disease substrate,
EBP health
coaching w/
feedback, early
follow-up prior to
discharge, address
comorbidities, at
home services
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Title

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)

Comprehensive
9.
Care Program
for Patients
with Chronic
Obstructive
Pulmonary
Disease: A
Randomized
Controlled
Trial

Ko et al.
(2017)

Assess whether a
comprehensive
care program
would decrease
hospital
readmissions and
LOS
Search Article
ASP
2/2020
Fit – Yes,
interventions for
managing COPD

Reducing
10.
COPD Hospital
Readmissions:
An official
ATS workshop
Report

Press, V.,
Au, D.,
Bourbeau,
M. et al.
(2018)

Workshop Report
on current best
practices and
models for
addressing COPD
readmissions

Type of
Evidence
Level /Quality
c-stat
Limitations

RCT
Level I B
SPSS 21,
intention to
treat,
binominal
regression,
Mann-Whitney
U test, Cox PH
model and log
rank test
Limits:
Unknown if
generalizable
outside of
China, 90%
male, longer
time of study
needed to see
if effects could
be maintained,
cost
effectiveness
not studied
Gray Lit
Level V A
Designs ranged
from QI to
value-based
models

Population
Inclusion/
Exclusion

Outcomes/
Results

180 patients June
2010-2012
Research clinic China
Intervention:
Nurse education,
Pulmonary
Rehabilitation, 3
monthly calls by
nurse x1 year,
respiratory specialist
every 3 months x 1
year
Inclusion:
Patients admitted with
AECOPD
Exclusion:
Age <40, Asthma, or
other chronic lung
disease, severely
limiting or terminal
disease, unable to
give informed consent

Primary endpoint:
hospital readmission
rate at 1 year
Secondary
endpoints:
QOL, mortality,
lung function, and
exercise capacity at
1 year
Results:
Comprehensive
COPD program can
reduce hospital
readmissions for
COPD and LOS, in
addition to
improving
symptoms and
quality of life

Clinicians,
researchers, payers,
program leaders,
nationally to present
and discuss 5 case
presentations with

Points of discussion:
Communicate,
Patient education,
Behavior
modification, Health
coaching,

Recommendati
ons or
Implications
for Study
Activate the
patient and
develop critical
health behaviors
Heterogeneity
of interventions,
population
studied, followup and outcome
difficult to
recommend but
comprehensive
individualized
care plans can
decrease
hospital
readmits and
LOS over 1 year
Further studies
to test which
component
contributes to
the desired
outcomes with
cost efficacy

Attention to
inability to
afford Rx, gaps
in care quality,
move beyond
30-day penalty
especially for

Times cited
Trust
Notes

Cited - 18
Trust - Yes

Cited - 8
Trust -Yes
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Title

Insights About
the Economic
Impact of
COPD
Readmissions
Post
Implementation
of the HRRP

Author/Ye
ar

Press, V.,
Konetzka,
R., &
White, S.
(2018)

Research Aim
Search Terms
Database
Dates
Fit (PICOT)
Fit – Yes, reported
risk stratification
tool, interventions

Type of
Evidence
Level /Quality
c-stat
Limitations
Statistical
Analysis/
c-stat – n/a but
comments on
c-stat
Limitations –
n/a

Describe insights
about the
economic impact
of
COPD readmissio
ns
Search Database
CINAHL,
Medline, Nexis
Uni
Topic:
Variable results
risk factors, higher
costs,
interventions,
significance of
problem

Expert Review
Level V B/C
Statistical
Analysis/
c-stat n/a
Limitations –
n/a

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

greatest potential for
success
Inclusion/Exclusion
(improve ID of
AECOPD upon
admission)
readmission reduction
programs
Single and multisite
Based on articles
published over 18
months
Inclusion/Exclusion
Evidence of
Significance and
Interventions related
to AECOPD
Readmissions

Guideline base
therapy,
Rigorous studies
w/RCT, Quality of
care to not focus on
30-day readmit,
Improve risk factor
identification and
high-risk patients
Interdisciplinary
teams, bundle care
interventions,
quality of care, and
improved process
measures
Results:
Success at reducing
readmissions and
cost savings varied
across the studies
The literature points
to factors and
conditions placing
patients at higher
risk of readmissions
and may lead to
higher costs
Interventions aimed
at reducing
readmissions after
index admissions for
AECOPD have
demonstrated
variable results

safety net
hospitals with
lower
socioeconomics

Times cited
Trust
Notes

Cited – 9
Trust –Yes
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Title

Author/Ye
ar

Research Aim
Search Terms
Database
Dates
Fit (PICOT)

Type of
Evidence
Level /Quality
c-stat
Limitations

Population
Inclusion/
Exclusion

Outcomes/
Results

Recommendati
ons or
Implications
for Study

Times cited
Trust
Notes

Most interventions
did not reflect costbased analyses
INTEGRATED CARE STUDIES
An overarching term for a broad and multi-component set of ideas and principles that seek to better co-ordinate care around people’s needs.
Merge key aspects in design and delivery of care systems that are fragmented (combine parts to form a whole) and provide attentive treatment to
patients in need to improve care/outcomes.
Effectiveness
Hernández Community-based RCT
Apr to Dec 2005, 155 Primary Aim:
The study
Cited - 19
of Community- (2015)
Integrated Care
Level I A
frail communityAssess IC
facilitated two
Trusted -Yes
Based
(IC) service in
t-test and x2
dwelling COPD
effectiveness in
key
How did they
Integrated Care
preventing
tests
randomly assigned
subset of COPD pop requirements for define “frail”
in Frail COPD
hospitalizations
multivariate
The IC intervention
that is high risk
adoption of IC
Did not reduce
Patients: A
and ED visits in
logistic and
(a) empower selfResults:
services in the
readmission but
RCT.
stable frail COPD
Cox regression management; (b)
IC statistically
community:
did reduce ED
patients
analysis
individualized care
enhanced self1.Change
use for
COPD and
STATA 10.0
plan; (c) access to a
management,
management,
admissions
hospital admission Limitations:
call center; and (d)
reduced anxiety and 2. Workforce
(coordinated
and risk
Not possible to coordination between depression and
preparation.
admission from
stratification; RCT id planned vs
the levels of care.
improved healthAppropriate
OP to IP) and
Google Scholar
unplanned
Hospital admissions,
related quality of
Populationmortality
NURS620 Search
readmissions.
ED visits and
life
based risk
2/2020
IC
mortality were
IC statistically
stratification for
Fit- Yes,
management
monitored for 6 years reduced ED visits
case findings
Intervention for
not adopted in
Inclusion Ag >45,
and mortality but
and individual
AECOPD
the community COPD related Dx
not hospital
risk prediction
thus was not
including TB, living
admission
of patients (age,
continued.
at home within the
No differences
frailty, severe
No included in hospital area
between the two
FEV1) to
clinical trials
Exclusion nursing
groups were seen
support
registry.
home, involved in
after 6 years
decision-making
Long delay
another study, death,
between data
unable to locate
collection and
reporting
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Appendix B Johns Hopkins Evidence-Based Practice
Synthesis and Evidence Tool
Category (Level Type)
Level I
∙ Experimental study
∙ Randomized Controlled Trial (RCT)
∙ Systematic review of RCTs with or without
meta-analysis

Total Number of
Sources/Level
RCT

Overall
Quality
Rating
A

Synthesis of Findings
Evidence That Answers the EBP Question
•
•
•

RCT

A

•

•
•
•
RCT

B

•
•
•

Systematic Review of 5
RCT

Level II

Experimental- quasi

B/C

A

•
•
•
•
•
•

Reduced readmissions 1, 3, 6, 9 mo but not 12 mo,
improved QOL and dyspnea score (Benzo et al.,
2016)
Intervention: Motivational Interviewing health
coaching with action plan, hotline
RN, RT
TC, F2F x1 (2 hour) then phone (weekly)
Decreased ED use and mortality improved selfmanagement but no decrease readmission.
Recommended appropriate risk stratification and
preparation of the community workforce
(Hernandez et al., 2015)
Intervention: Integrated Care intervention (using
communication, self-management, pulmonary
nurse, hotline)
Specialty respiratory RN
Home visit (2 hr with specialty RN, PCP, nurse,
SW) (3 day then frequency tailored to patient)
Reduced readmissions 12 mo (Ko et al., 2017)
Intervention: Comprehensive Care Communication,
GBT, hotline
Respiratory physician (initial and if necessary,
thereafter) and respiratory nurse, Physiotherapist,
PCP
TC, community
Reduced readmissions 6-12 months
Intervention: Multiple communications, patient
hotline and COPD patient education (PrietoCenturion et al., 2014)
RN, RN-SW-MD, RN-PT-RT
Home visits, Calls (monthly)
Overarching goal reduced readmission
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Category (Level Type)

Total Number of
Sources/Level

Overall
Quality
Rating

Synthesis of Findings
Evidence That Answers the EBP Question
•

∙ Quasi-experimental studies
∙ Systematic review of a combination of RCTs and
quasi-experimental studies, or quasi-experimental
studies only, with or without meta-analysis

•
•
Experimental- quasi

A

•
•

Level III
∙ Non-experimental study
∙ Systematic review of a combination of RCTs,
quasi-experimental, and non-experimental
studies, or non-experimental studies only, with or
without meta-analysis
∙ Qualitative study or systematic review of
qualitative studies with or without meta-synthesis

•
•

Systematic Review
Qualitative Synthesis

B

Systematic Review
Qualitative Synthesis

B

Non-experimental

A/B

•
•

Non-experimental

B

•
•

•
•
•

Intervention: Pilot SM with action plan, hotline, MI
produced no harm, improved patient satisfaction
(Benzo et al., 2013)
RN, RT
F2F (weekly)
Risk stratification predicts readmission and death
30, 90 days
COPD patients for high risk of readmission or
death identified with good c-stats using the PEARL
tool for risk stratification with a summary of
interventions, resources, recommendations to
reduce risk of readmissions (Echevarria et al.,
2017)
Identified high-risk readmissions at 30 day
Readmission PM needed to identify high risk
patients and interventions compatible with clinical
workflows and administrative use for resource
allocation (Kansagara et al., 2011)
Functional and Social variables improved PM
PMs for risk stratification 2 weeks - years
Multimorbidity are strong predictors for
readmissions (Alonso-Moran et al., 2015)
Risk factors predict readmission at 30 day
Readmissions are associated with identified patient
and clinical factors. A COPD-specific risk
stratification algorithm is needed reflecting these
factors (Jacobs et al., 2018)
Predictors of 30-day readmissions
Risk stratification and mortality prognosis
associated with specific comorbidities including
(Krishnan et al., 2019)
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Category (Level Type)

Total Number of
Sources/Level

Overall
Quality
Rating

Synthesis of Findings
Evidence That Answers the EBP Question

Level IV
∙ Opinion of respected authorities and/or reports of
nationally recognized expert
committees/consensus panels based on scientific
evidence

N/A

N/A

N/A

Level V
∙ Evidence obtained from literature reviews, quality
improvement, program evaluation, financial
evaluation, or case reports
∙ Opinion of nationally recognized expert(s) based
on experiential evidence

Integrative Review of
RCT, PM

A

•
•

•
•
Integrative Review of 3
RCTs, 1 meta-analysis,
4 non-RCTs

A

•
•
•
•

Professional Society
Workshop Report

A

•
•

•

Models of care to reduce readmissions 30 days – 2
years
Intervention: Transitional Care to community with
patient education, action plan, SM, communication,
adapting to patient-specific situation, disease
severity, comorbidities, access to care telemedicine.
Need transitional studies from acute care to
community care (Bourbeau & Echevarria, 2020)
Health coaches, case managers or health
navigators, health care professionals
PR, Community (increase care contact with higher
risk)
Decrease 30-day preventable all-cause
readmissions (Mora et al., 2017)
Intervention: NP-led Transitional Care patient
hotline, communications
NP, PCP
Home visits, phone calls (3-day, weekly)
Focus and quality beyond 30 days readmit
Intervention: Comprehensive 1. Communication, 2.
Patient adherence, education, SM, MI, health
coaching, prompt access to care 3. GBT and
include multimorbidity and social determinants, 4.
Rigorous study designs needed, 5. Address quality
with mortality metrics, patient satisfaction,
symptoms and exercise tolerance 6. Identification
risk factors and high-risk patients (Press et al.,
2018)
RN, NP, PR, Pulmonary Physician champion
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Category (Level Type)

Total Number of
Sources/Level

Quality Improvement
Report

Overall
Quality
Rating

A/B

Synthesis of Findings
Evidence That Answers the EBP Question
•

Home visit care manager, specialty clinic, econsults (2-3 days, within 1 week)

•
•

Reduced 30-day readmission rate
Intervention: Retrospective review evaluating cause
of readmissions for areas of improvement using a
face validated tool for risk stratification and
transitional care. (Deniger et al., 2015)
NP (for high risk) and RN (for moderate risk)
home visit within 48 hrs followed by phone visits
prn for highest risk group and telephone call within
72 hrs then prn for moderate risk

•
•

Quality Improvement
Report

Integrated review but
w/o identified search
strategy or consistently
defined study design of
publications reviewed

B

B/C

•
•

•
•
•
•

•
•

Reduced 30-day readmission rate
Intervention: Transitional Care pilot PR, SM,
follow up communications and phone calls, GBT,
targeted interventions in high-risk group have
greatest potential to reduce readmissions (Blaha et
al., 2018)
Specialists, RN, PCP, health coach
Home visits, telehealth, PR (weekly)
Reduced readmission 30 days
Intervention: Comprehensive care management
with identified risks table, communication, SM,
education teach to goal, early follow up, evaluated
policies for HRRP on goals and value-based care
(Shah et al., 2016)
RN, RT, pulmonologist, PCP
Home visits, telehealth (within 1 week)
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COPD Chronic Obstructive Pulmonary Disease
EBP Evidence-Based Practice
F2F Face to Face Pulmonary Clinic Visit
GBT Guideline-Based Therapy
HRRP Hospital Readmission Reduction Program
NP Nurse Practitioner
PCP Primary Care Provider
PM Predictive Model
PR Pulmonary Rehabilitation
PT Physical Therapist
RCT Randomized Control Trial
RN Registered Nurse
RT Respiratory Therapist
SM Self-Management
SW Social Worker
TC Transitional Care
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Appendix C PEARL Risk Stratification Tool

Echevarria, C., Steer, J., Heslop-Marshall, K., Stenton, S. C., Hickey, P. M., Hughes, R., … Bourke, S. C. (2017). The PEARL score
predicts 90-day readmission or death after hospitalization for acute exacerbation of COPD. Thorax, 72(8), 686–693.
https://doi.org/10.1136/thoraxjnl-2016-209298 (S. Bourke, personal communication, June 26, 2020). Reproduced with permission for
open and free use.
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Appendix D Stetler Theoretical Model

Stetler, C. (2001). From, Updating the Stetler Model of research utilization to facilitate evidence-based practice. Nursing Outlook,
49(6). Retrieved from https://doi.org/10.1067/mno.2001.120517. Copyright © 2001 by Mosby, Inc. No permission for use required.
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Appendix E Logic Model
Resources*/Inputs

Activities

Outputs

Outcomes: Short
term

Outcomes:
Intermediate

Outcomes:
Long term

What we invest:
resources and
contributions

What we do

What we accomplish
or produce from the
activities

Who we
reach with
our
activities

The expected
changes attainable
during the DNP
Scholarly Project
timeline.

The expected
changes
attainable 6
months - 2
years after the
DNP Project is
implemented.

Fundamental
changes for
participants or
community
because of
project
activities, 3-5
years after
project
implementation.

Human
Stakeholders, Center
for Excellence, IRB
Health System
Partners, Providers,
Computer Personnel
(Coders) Clinic
Managers
Organization
Computer,
Audiovisual, Office
Supplies,
Meeting space, medical
devices,
Pulmonary Function
Testing (PFT) lab
Financial:
Cost of medical
devices for patient care
using telehealth,
Transportation if
domicile care

•

•

Patients

1.

11. Two additional
system sites offer
access to the
pulmonary clinic
within 1-2 years
following the SP
(PO)

16. COPD hospital
readmissions
decreased by 2%
within 3-5 years
after system-wide
patient-specific
preventive care
measures
implemented

•
•
•

•

Schedule meetings
for the following
activities/actions:
Approval for SP pilot
(done 9/2020)
Agree on process to
confirm diagnosis
Develop transition
from hospital
discharge to
pulmonary clinic
process
(communication/
message, referral,
ICD9/10 AECOPD,
COPD, Respiratory
failure as
primary/secondary
diagnosis,
inclusion/exclusion)
Define pulmonary
clinic visit: 1-2

Patients have timely
access to the pulmonary
clinic

2.

50% of COPD
patients referred to
the pulmonary
clinic are seen
within 7-14 days of
discharge (PO)
50% of COPD
patients referred to
the pulmonary
clinic access 3 out
of 4 outpatient
pulmonary clinic
visits within 30
days s/p discharge
(PO)

Tool: Data spreadsheet
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Resources*/Inputs

Activities

•

•
Human:
Providers, Computer
Personnel, Clinic Staff,
Clinic Management
Organization:
Computer, Office
supplies, medical
devices
Financial:
Cost of personnel time
for training and
building templates,
data entry and analysis,
Costs of medical
devices and office
supplies

•

•

•

provider(s), timing
(days/wks./months)
and length of visit (30
and 60 min), location
(clinic, telehealth,
domicile)
Develop
collaborating
guidelines with
physicians
Develop audit/data
spreadsheet
Create EHR COPD
template using
technology (hotline
calls and pulmonary
care visits) to include
who (at least one
provider, 1-2 MA),
does what during
encounter (includes
risk stratification tool
(PEARL*), tables for
risks, motivations,
barriers, eMRCD*,
GBT*, comorbidity
using SOAP* format)
Training event for
EHR COPD template
by project lead X2
(initial and follow up)
Develop attendance
record

Outputs

•
•
•

EHR COPD template
created
Training completed for
template use by X
number of people
Document,
communicate/advocate
and coordinate timely
patient care needs with
the patient care team
that impacts preventive
care to improve
outcomes and reduce
readmissions

Outcomes: Short
term

Patients and
care team,
Clinic Staff (12 MAs)

3.

At least 1
pulmonary
provider(s), and
staff (1-2 MA) in
the healthcare
facility pulmonary
clinic receive
training by the
project lead to use
the EHR COPD
template by the end
of May 2021
(CO/PO)

Tool:
In-person meeting for
training,
EHR COPD template,
Data spreadsheet
Forms survey

Outcomes:
Intermediate

Outcomes:
Long term

12. 90% of COPD
patients in the
pulmonary clinic
have their care
plan
communicated to
the PCP, care
team at the time of
the patient clinic
visit (CO/PO)

17. Developed
system-wide
interprofessional
communication
pathway between
hospitals and
community levels
within 3-5 years
(this will include
hospital COPD
stakeholders,
pulmonary clinic,
palliative care,
primary care,
rehabilitation,
nursing, respiratory
care, pharmacy,
social work,
population health
and patients (“full
cycle care” (Hickey
& Brosnan, 2017)
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Resources*/Inputs

Activities

Human:
Computer Personnel
Providers, Clinic Staff
(MAs), Patients
Organization:
Clinic Space,
Computer
Financial:
Cost of personnel time
during routine
pulmonary clinic visit

•

Human:
Computer Personnel,
Providers, Clinic Staff,
Patients
Organization:
Clinic Space,
Computer
Financial:
Cost of personnel time
for training and
building templates,
data entry and analysis,
Costs of office supplies

•

•
•

•

•

Outputs

1-2 Provider(s), 1-2
clinic staff (MAs)
action/complete risk
stratification tool in
EHR COPD template
during the pulmonary
clinic visit based on
completed training
Develop audit/data
spreadsheet
Select Likert
Satisfaction tool
(provider post-test)

•

Develop and embed
motivation scale
(pre/post test) in her
COPD template
1-2 Provider(s), 1-2
clinic staff (MAs)
complete
motivational
assessment in EHR
during the pulmonary
clinic visit based on
completed training
Develop audit/data
spreadsheet

•

•

•

Outcomes: Short
term

Risk stratification tool
use during the
pulmonary clinic visit
Patients receive risk
stratification identifying
higher risk patient
population that requires
focused, patient-specific
interventions and
intensified resource
allocation

Providers and
Patients

Motivations table
template created
Patient motivation is
identified to improve
outcomes and reduce
readmissions

Patients and
Providers

4.

80% of COPD
patients in the
healthcare facility
pulmonary clinic
have risk
stratification
documentation in
the EHR or data
spreadsheet by the
2nd pulmonary
clinic visit or
between June and
by the end of
August 2021(CO).
Tools:
EHR audit PEARL,
Data Spreadsheet,
Likert provider post-test
5. 80% of COPD
patients in the
pulmonary clinic
are able to identify
patient- specific
motivation
impacting patient
care as documented
in the EHR by the
2nd pulmonary
clinic visit between
June and by the end
of August 2021
(CO)
Tool:
Data Spreadsheet,

Outcomes:
Intermediate

Outcomes:
Long term

13. 80% of COPD
patients at highest
risk for resource
utilization are
identified systemwide within 1-2
years of
implementing risk
stratification

16. COPD hospital
readmissions
decreased by 2%
within 3-5 years
after system-wide
patient-specific
preventive care
measures
implemented

14. Resource
allocation budget
approval
coordinated with
Stakeholders
within 1-2 years
for preventive care
measures to help
patients manage
COPD (PO)

16. COPD hospital
readmissions
decreased by 2%
within 3-5 years
after system-wide
patient-specific
preventive care
measures
implemented
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Resources*/Inputs

Human:
Computer Personnel,
Providers, Clinic Staff,
Patients
Organization: Clinic
Space, Computer
Financial:
Cost of personnel time
for training and
building templates,
data entry and analysis,
Costs of office supplies

Activities

•

•

•

Human:
Stakeholders,
Providers, Clinic Staff,
Computer Personnel,
Patients
Organization:
Clinic Space,
Computer
Financial:

•

•

Develop and embed
checklist table of risk
factor with SDoH
template in EHR
1-2 Provider(s), 1-2
clinic staff (MAs)
complete risk factor
assessment in EHR
COPD template
during the pulmonary
care visit based on
completed training
Develop audit/data
spreadsheet

Develop and embed
open ended question
in EHR COPD
template
1-2 Provider(s), 1-2
clinic staff (MAs)
complete patient
beliefs and barriers in
EHR during the
pulmonary care visit

Outputs

•
•

•
•

Risk factor with SDoH
checklist table template
created
Patient-unique risk
factors with SDoH are
identified that require
specific attention to
improve outcomes and
reduce readmissions

Barriers question created
Patients and
Stakeholders understand
patient beliefs and
barriers that may
interfere with the care
plan interventions, poor
outcomes and contribute
to readmissions

Outcomes: Short
term

Patients and
Providers

Patients,
Providers and
Stakeholders

Patient Interview,
Likert patient
motivation pre/post-test)
6. 80% of COPD
patients in the
pulmonary clinic
are able to identify
at least one patientspecific risk
factor(s) including
SDoH for
AECOPD
documented in the
EHR by the 2nd
pulmonary clinic
visit between June
and by the end of
August 2021 (CO)
Tool:
Data Spreadsheet,
Patient interview,
Multiple Choice
Checklist
7. 80% of COPD
patients in the
healthcare facility
pulmonary clinic
can identify at least
1 patient- specific
perceived barrier(s)
impacting patient

Outcomes:
Intermediate

Outcomes:
Long term

14. Resource
allocation budget
approval
coordinated with
Stakeholders
within 1-2 years
for preventive care
measures to help
patients manage
COPD (PO)

16. COPD hospital
readmissions
decreased by 2%
within 3-5 years
after system-wide
patient-specific
preventive care
measures
implemented

14. Resource
allocation budget
approval
coordinated with
Stakeholders
within 1-2 years
for preventive care
measures to help
patients manage
COPD (PO)

16. COPD hospital
readmissions
decreased by 2%
within 3-5 years
after system-wide
patient-specific
preventive care
measures
implemented

104

Resources*/Inputs

Activities

Cost of personnel time
for training and
building templates,
data entry and analysis,
Costs of office supplies

Human:
Stakeholders (CNE),
Providers, Clinic
Managers, Hospital
and Clinic Staff,
Computer Personnel
Organization:
Clinic Space,
Computer, Office
Supplies
Patients
Human:
Organization:
Computer,
Audiovisual, Office
Supplies
Financial:
Cost of training and
using personnel time
during routine patient
pulmonary care visit
Costs of office supplies

Outputs

Outcomes: Short
term

based on completed
training

•
•

Develop audit/data
spreadsheet
Select Likert
Knowledge Scale
(post-test patient)

Outcomes:
Intermediate

Outcomes:
Long term

care documented in
the EHR by the 2nd
visit between June
and by the end of
August 2021 as
measured by EHR
audit or data
spreadsheet tool
(CO)

•

•

•

Patient care experience
scale created with one
patient measure from
interview using postrating 1-5:
Patient: “Overall, how
helpful was this project
to your understanding of
your medical
condition?”
(Course/Project
evaluation or Post-Visit
Patient Satisfaction)

Patients and
caregivers

Tools:
Data Spreadsheet,
Patient interview
8. 80% of COPD
patients in the
healthcare facility
pulmonary clinic
report their care
experience by the
end of August 2021
(CO)
Tool:
Likert Scale

15. 80% of COPD
patients referred to
pulmonary clinic
identify their
patient care
experience (CO)

16. COPD hospital
readmissions
decreased by 2%
within 3-5 years
after system-wide
patient-specific
preventive care
measures
implemented
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Resources*/Inputs

Human:
Stakeholders,
Providers, Computer
Personnel, Hospital
and Clinic Staff, Clinic
Management
Organization: Clinic
Space, Computer,
Office Supplies
Financial:
Cost of personnel time

Activities

•

•

•

Patient pulmonary
clinic visits
forwarded to patient
care team
Agree how to
document sent/faxed
external
communication
within EHR
Develop audit/data
spreadsheet

Outputs

•

Document,
communicate/advocate
and coordinate timely
patient care needs with
the patient care team at
pulmonary clinic visits
and at time of agreed
transfer back to PCP

Outcomes: Short
term

Patients and
care team

9.

80% of COPD
patients in the
healthcare facility
pulmonary clinic
have their care plan
communicated to
the PCP and/or care
team between June
and by the end of
August 2021
(CO/PO)

Outcomes:
Intermediate

Outcomes:
Long term

12. 90% of COPD
patients in the
pulmonary clinic
have their care
plan
communicated to
the PCP, care
team at the time of
the patient
pulmonary clinic
visit (CO/PO)

17. Developed
system-wide
interprofessional
communication
pathway between
hospitals and
community levels
within 3-5 years
(this will include
hospital COPD
stakeholders,
pulmonary clinic
palliative care,
primary care,
rehabilitation,
nursing, respiratory
care, pharmacy,
social work,
population health
and patients (“full
cycle care” (Hickey
& Brosnan, 2017)
18. Predictive
modeling
coordinated with
Stakeholders within
3-5 years for
preventive care
measures to help
patients manage
COPD

Tool:
Data spreadsheet

Human:
Stakeholders, Health
System Foundation,
Champions,
Computer Personnel
Organization:
Office space,
Computer, Office
supplies
Financial:

•

•

Create a report and
communicate using
technology/virtual
meeting high risk
patient needs
Provide
recommendations for
patient resource
allocation

•
•

Document created and
filled out
Communication of
resources needed to
provide patient-specific
care that impacts ability
to provide preventive
care to improve
outcomes and reduce
readmissions

Stakeholders,
Providers and
Patients

10. Document of
project outcomes:
readmission rate,
risk stratification,
resource and
support services
needed for valuebased care
communicated to

14. Resource
allocation budget
approval
coordinated with
Stakeholders
within 1-2 years
for preventive care
measures to help
patients manage
COPD (PO)
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Resources*/Inputs
Cost of personnel time

Activities

Outputs

Outcomes: Short
term

Outcomes:
Intermediate

Outcomes:
Long term

Stakeholders by the
end of May 2022
(PO)

Tool:
Report and/or
PowerPoint presentation
*PI Principle Investigator, *Risk stratification tool is the PEARL (Echevarria et al., 2017b) throughout the logic model, *eMRCD dyspnea scale, *GBT
Guideline-Based Therapy, *SOAP Subjective Objective Assessment Plan patient’s pulmonary clinic visit note
Resources
Personnel:
• Stakeholders: Administration (Acute Care Service Line), Nursing Leadership (Chief Nursing Officer, Center for Nursing Excellence)
• Champions (Pulmonary Specialty Physicians)
• Providers (pulmonary physicians, nurse practitioner, physician assistants)
• Hospital staff (? discharge planner, 3 COPD educators, ? pulmonary rehabilitation, call center)
• Clinic Staff (1-2 trained: MA, RT, schedulers, front office, medical records, call center)
• Computer personnel: IT, Data analytics, EHR/EPIC builders, Coders (1 each)
• Clinic managers
• Faculty
Supplies & Equipment:
• Computer (1 each for personnel involved, ~15)
• Office supplies: Paper, printer (1), ink cartridge, pens, highlighters, stapler/staples, binder clips, telephones (2)
• Medical devices: telehealth iPad/iPhone, stethoscopes, oximeters, vital sign equipment (1 each)
Space:
• Hospital, Clinic (Exam rooms (1-2), PFT lab (1), Online TEAMS meeting space, Transportation to locations)
From, Adapted from, Logic Model Foundation Development Guide, pg. 4.
http://www.wkkf.org/resource-directory/resource/2006/02/wk-kellogg-foundation-logic-model-development-guide.
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Appendix F Risk Factors and Social Determinants of Health
Risk Factors/SDoH Table
COPD Readmission prior 30 days
Prior all cause Hospitalization
Length of Stay <2 >5days
Comorbidity: Respiratory, Cardiac or
Pneumonia
Comorbidity (3 or more of the
following: HF, CVD, HTN, PVD,
Dysrhythmias, Bronchiectasis,
Infection, Anemia, CA, GERD,
Dysphagia, DM, Liver Disorder, Renal
Failure, OP, OSA, Cognitive
Impairment,
Psych/Depression/Anxiety)
Polypharmacy >/=7 or High Risk Rx
(anticoag, digoxin, diuretic,
narcotic/benzo, insulin)
Social Support (married, children)
Lacking or None
Discharge to SNF, LTC in past 6
months:
Clinical Judgement for Risk/Failure
Score risk factors/SDoH:
0-3 (Moderate), score >/=4 (High)

{Yes (1 Point) No:1600000101}
{Yes (1 Point) No:1600000101}
{Yes (1 Point) No:1600000101}
{Yes (1 Point) No:1600000101}
{Yes (1 Point) No:1600000101}

{Yes (1 Point) No:1600000101}
{Yes (1 Point) No:1600000101}
{Yes (1 Point) No:1600000101}
{Yes (1 Point) No:1600000101}
{NUMBERS; 0-9:23973}

Appendix F. Adapted from, Deniger, A., Troller, P., & Kennelty, K. A. (2015). Geriatric
Transitional Care and Readmissions Review. The Journal for Nurse Practitioners, 11(2), 248–
252. https://doi.org/https://doi.org/10.1016/j.nurpra.2014.08.014. (A. Deniger, personal
communication, October, 2020). Adapted with permission
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Appendix G Memorandum of Understanding
Memorandum of Understanding
Between
Xx, Doctor of Nursing Practice (DNP) student
Xxx
and
Xxxx
This Memorandum of Understanding (MOU) outlines the terms and understanding between the
Xx, a DNP student at Xxx, and Xxxx to pilot a Chronic Obstructive Pulmonary Disease (COPD)
readmission project implementing patient risk stratification and facilitating resource allocation.
Background
COPD affects 250 million people worldwide and contributes to the third leading cause of death
globally, nationally, and locally (Heron, 2019; Idaho Department of Health and Welfare
[IDHW], 2017; World Health Organization [WHO], 2019). The cost of COPD is near $50 billion
in the U.S. and acute exacerbation COPD contributes to 70% of COPD-related health care costs
and over $15 billion annually for hospital readmissions ( Centers for Disease Control and
Preventions [CDC], 2020; Press et al., 2018). The local COPD readmission rate is high and
comparable to the national rate at 19.5% (Medicare, n.d.). High readmission rates due to COPD
have a negative financial and cultural impact on hospital systems. Medicare penalizes health care
institutions up to 3% of reimbursements for hospital readmissions (CMS, 2012). Patients with
COPD readmissions have high co-morbidities, complex medical needs and to date, there is no
single intervention to reduce readmissions (Dal Negro et al., 2015; Press et al., 2018). There is
growing advocacy to identify patients who are the top percent users of health care resources and
how to support these patients in the health care setting and in their community setting (Mitchell,
2019; RWJF, 2017). Risk stratification is a process that predicts patients at highest risk for
resource utilization in order to help prioritize patient-specific, highly complex, time and staff
consuming interventions (Crane et al., 2010; Press et al., 2018; Scalable Health, 2018).
Identifying and managing high risk populations to track improvement in outcomes over time,
demonstrates value to payers known as value-based care (National Council Organization, 2017).
Focus is needed for highly intense, quality of care aimed at patient-specific risk stratification,
patient-specific risk factor identification and preventive care with strategically allocated
resources in outpatient and community settings (Benzo et al., 2013, 2016; Kalhan & Mutharason,
2018; Press et al., 2018).
Purpose
The aims of this pilot project are using expedited transitional care from the time of hospital
discharge to outpatient specialty care to identify moderate and high-risk patients through risk
stratification, target preventive care interventions through highly intense evaluations, and
communicate patient-specific needs for resource allocation.
Intended Project Outcomes

109

•
•
•

Improved identification of patients with moderate to high risk for COPD readmission
Improved communication of patient-specific risks, motivations and barriers to care
Improved communication for resource allocation specific to higher risk patient needs

Duration
The Scholarly Project will begin within the healthcare facility February 2021 and end April
2022. The initial work starts in February 2021 with the inception of planning activities and
training for the implementation phase. The implementation of the project for data collection
initiates May 2021 and ends August 2021. Data analysis and evaluation continues through
February 2022. The project culminates at the end April 2022 with the dissemination of
information in a final report.
Reporting
The DNP Scholarly Project will include a final report, an abstract and an oral presentation of the
report for potential publication by April 2022. Interim discussions or reports will be provided
throughout the project timeline at the discretion of the DNP student and healthcare facility. The
DNP student will submit a Final Project Report for publication in Scholarworks. Scholarworks is
a collection of services designed to capture and showcase all scholarly output by the Xxx
community, including doctoral dissertations and doctoral project reports.
The final document will be submitted for approval to the Nursing Research Director in the
Nursing and Patient Care Center of Excellence. XXXXXXXXX research determination letter
will outline specific ethics for the documentation and sharing of information.
No personal identifiers will be included, and all data will be reported in aggregate form. The
author welcomes any comments or suggestions from the Xxxx but reserves the right to publish
findings and analysis according to professional standards and principles of academic freedom.
For any work of a scholarly nature, the author agrees to follow the healthcare facility preferences
in how it is to be named (or not) in the work.
Agency preferences for how they are named/referred to within the student’s work
The organization will be referred to as a healthcare facility in the intermountain west in school
documents, abstract, publication, final report, and professional presentations.
Student and Healthcare Facility Contact
_______________________ Date:
(DNP Student signature)
Xx, Xxx DNP student
_______________________ Date:
(Healthcare Facility Contact signature)
Xx, DNP, RN, NEA-BC, RNC-OB, Senior Director, Nursing & Patient Care Center of
Excellence, Xxxx
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Appendix H COPD Template
Date of Visit: @TD3@
Patient Name: @NAME@
Date of Birth: @DOB@
PCP: @PCP@
REASON FOR VISIT: @CCN@
In an effort to avoid potential COVID-19 exposure in this patient, this visit occurred by
telehealth. Verbal consent {STOP if was not:25643::was} obtained from patient, parent
or guardian to provide telehealth services after informed of risks, benefits and
alternatives.
Patient identification completed: {Yes/No:2::Yes}
Mode of Communication: {Blank:19197::"Telephone", "Video"}
{If Video specify application (Optional):37698}
Patient Location: {State Location:37697::Idaho}, {Blank:19197::"Home Residence"}
Provider Location: {Blank:19197::"Clinic"}
{Telehealth Time Coding (Optional):38424}
Subjective:
@NAME@ is a pleasant @AGE@ {desc; ethnicity:30356} @SEX@ who presents for
follow up on COPD.
Individuals present include: {LG Patient/Caregiver:40345}
VISIT (insert COPD Visit 1, 2, 3 or 4)
Insert appropriate Visit 1-4 under Subjective:
VISIT 1/4 Hospital Followup, Risk Stratification, Emergency Action Plan, GBT
Since discharge or last visit, any all-cause re-hospitalizations or ED/UC:
{YES/NO/***:38137} Date: ***
Tell me what you understand about your most recent hospitalization: ***
Current Symptoms:
Cough {Desc; cough:27341}
Wheeze {DESC NONE OCCASIONAL DAILY CHANGE FROM
BASELINE:2100022902}
Chest pain {desc; chest pain:17949}
SOB: ***
• PEARL (see E below)
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PEARL Tool (Echevarria et al., 2017) prediction of readmission or death
P
Prior Admission (>/=2)
{Yes3/No/:40354}
Admission to inpatient hospital, not
Ambulatory or day surgery
E
eMRCD 4 (stops to breath after about
{Yes1/No/:40373}
only score
100m or after a few minutes on level
the
ground)
worse/highe eMRCD5a (too breathless to leave the
{Yes2/No:40374}
st value (4,
house unassisted but can independently
5a or 5b)
shower/dress
eMRCD 5b (too breathless to leave the
{Yes3/No/:40354}
house unassisted and requires help with
shower/dress)
A
Age (>80)
{Yes1/No/:40373}
R
Right sided heart failure (with or without {Yes1/No/:40373}
imaging of Echo or CXR, or based on
clinical s/s age >45, FEV1 <50%, Pa02
<55 or C02 >45, ankle edema, JVD,
ascites, EKG)
L
Left sided heart failure (screen with
{Yes1/No/:40373}
s/s/BNP but must be confirmed on Echo
to score, cannot be clinical)
Total PEARL Score
{numbers 112:10294}
PEARL 0-1 (low risk) = 20.7% (return to
PCP)
PEARL 2-4 (moderate risk) =42.1%
(followup SLIPA)
PEARL >5 (high risk) = 66.4% (followup
SLIPA)
Do you need help around the house: {YES/NO/***:38137}
What are you doing for your health right now: ***
Rx:
Inhaler names: ***
Are the inhalers helpful: {YES/NO/***:38137}
Oxygen therapy: {IFT OXYGEN:304010602}
PAP therapy: {YES/NO/***:38137}
Adherence: {Adherence:33815}
Do you have a plan in the event that your breathing is worsening? {LG Breathing
Worse Plan:40349}
Routine Exercise or Pulm Rehab: {Yes/No/NA/:32993}
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Priority self-management behavior for pulmonary care
What do you value/enjoy/think about most often: ***
What are your strengths: {BH Strengths:39839}
What is a priority you would like to work on that could improve your
health/situation: {LG Health/Situation Priority:40350:a}
Connect thoughts and behaviors with values, strengths, and priorities.
What would you be willing to try before our next meeting? ***
Motivational Questions
"How important is it for you to manage your COPD?" {NUMBERS; 1-10 (OUT OF
10):10902}
"Why it {IS/ IS NOT:23127} important?" ***
"How confident are you that you can help manage your COPD?" {NUMBERS; 1-10
(OUT OF 10):10902}
"How would you change your confidence level ?" ***
What seems most personally relevant to you of all we have discussed today: ***
Reflect and summarize then confirm interview captured the discussion.
Review risk stratification level (see PEARL), emergency action plan, GBT, revise as
needed and if readmitted
Describe what to expect next Visit 2: symptoms/emergency plan, self-management,
Risk Factors, Priorities, Barriers to Care.
Insert appropriate Visit 1-4 under Subjective:
VISIT 2/4 Risk Factors/Social Determinants, Priority of Care, Barriers to Care
Since discharge or last visit, any all-cause re-hospitalizations or ED/UC:
{YES/NO/***:38137} Date: ***
Current symptoms:
SOB {DESC NONE OCCASIONAL DAILY CHANGE FROM BASELINE:2100022069}
Cough {Desc; cough:27341}
Wheeze {DESC NONE OCCASIONAL DAILY CHANGE FROM
BASELINE:2100022902}
Chest pain {desc; chest pain:17949}
Rx:
Inhaler names: ***
Oxygen therapy: {IFT OXYGEN:304010602}
PAP therapy: {YES/NO/***:38137}
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Adherence: {Adherence:33815}
Do you have a plan in the event that your breathing is worsening? {LG Breathing
Worse Plan:40349}
How did work go on your self-management activity from last visit? {LG Self
Management Activity :40352}
Negotiate a new plan or continue plan, or modify plan.
Connect thoughts, behaviors and goals to values, strengths and priorities from prior visit
Review VISIT 1, risk stratification, emergency plan, GBT, education, revise as needed
Risk Factors/SDoH Table
COPD Readmission prior 30 days
Prior all cause Hospitalization
Length of Stay <2 >5days
Comorbidity: Respiratory, Cardiac or
Pneumonia
Comorbidity (3 or more of the
following: HF, CVD, HTN, PVD,
Dysrhythmias, Bronchiectasis,
Infection, Anemia, CA, GERD,
Dysphagia, DM, Liver Disorder, Renal
Failure, OP, OSA, Cognitive
Impairment,
Psych/Depression/Anxiety)
Polypharmacy >/=7 or High Risk Rx
(anticoag, digoxin, diuretic,
narcotic/benzo, insulin)
Social Support (married, children)
Lacking or None
Discharge to SNF, LTC in past 6
months:
Clinical Judgement for Risk/Failure
Score risk factors/SDoH:
0-3 (Moderate), score >/=4 (High)

{Yes (1 Point) No:1600000101}
{Yes (1 Point) No:1600000101}
{Yes (1 Point) No:1600000101}
{Yes (1 Point) No:1600000101}
{Yes (1 Point) No:1600000101}

{Yes (1 Point) No:1600000101}
{Yes (1 Point) No:1600000101}
{Yes (1 Point) No:1600000101}
{Yes (1 Point) No:1600000101}
{NUMBERS; 0-9:23973}

Additional Risk Factors Table:
{LG Additional Risk Factors:40353:p}
Age >75-80, Culture (AI/AN higher local risk), Gender (women higher risk), Drugs
(Illicit), Smoking, Air Pollution, Deconditioning, Frailty (Quad size, 6MWT speed), Falls 2
or more or any in the past year, Low self-health, Unemployment, Low income level
(does not own home), Low education level (less than HS education), State insurances,
Medication or Vaccination Non-adherence, Medication (access or technique)
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Barriers to Care
Do you think your risk factor score and risk factors above affect your care:
{Yes/No/NA/:32993}
Do you feel you have personal barriers to your care and what are they:
{Yes/No/NA/:32993}
Use affirmation and reflection.
Connect thoughts and behaviors with values, strengths, and priorities.
What would you be willing to try before our next meeting? ***
What seems most personally relevant to you of all we have discussed today: ***
Reflect and summarize then confirm interview captured the discussion.
Describe what to expect next Visit 3: Self-management and Goals of care (in-person
visit if possible). Revise and update at each visit and if needed readmissions
Insert appropriate Visit 1-4 under Subjective:
VISIT 3/4 Goals of Care
Since discharge or last visit, any all-cause re-hospitalizations or ED/UC:
{YES/NO/***:38137} Date: ***
Current symptoms:
SOB {DESC NONE OCCASIONAL DAILY CHANGE FROM BASELINE:2100022069}
Cough {Desc; cough:27341}
Wheeze {DESC NONE OCCASIONAL DAILY CHANGE FROM
BASELINE:2100022902}
Chest pain {desc; chest pain:17949}
Rx:
Inhaler names: ***
Oxygen therapy: {IFT OXYGEN:304010602}
PAP therapy: {YES/NO/***:38137}
Adherence: {Adherence:33815}
Do you have a plan in the event that your breathing is worsening? {LG Breathing
Worse Plan:40349}
Review Visits 1 and 2 risk stratification level, emergency plan, GBT, Risk Factors/Social
Determinants, Priorities and Barriers to Care, revise and/or add a new goal
How did work go on your self-management activity from last visit? {LG Self
Management Activity :40352}
Negotiate a new plan or continue plan, or modify plan.
Connect thoughts, behaviors and goals to values, strengths and priorities from Visits 1
and 2 or that are new
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Goals of Care
Acknowledge these can be meaningful and rewarding but difficult discussions to work
through: {YES/NO/***:38137}
In the event you are unable to speak for yourself, who speaks for you? ***
What is your understanding of your lung disease? {DESC;
STABLE/IMPROVING/WORSENING:2100020620} {Prognosis:23446}
What is your understanding of what impacts your lung disease? ***
What are you hoping for or your expectations? ***
What do you not want to happen? ***
What is important to you in our care for you? {LG Important Care:40355}
What support or resources do you have or need? {LG Support/Resource:40356}
Do you have an advance directive and/or POST form (confirm in snapshot):
{YES/NO/***:38137}
If needed discuss CPR outcomes, survival, quality of life post resuscitation:
{YES/NO/***:38137}
What seems most personally relevant to you of all we have discussed today: ***
Connects thoughts, behaviors and goals to values, strengths and priorities set
previously
Describe what to expect next Visit 4 and future visits: Review visits 1, 2 and 3. Revise
and update at each visit and if needed readmissions
Insert appropriate Visit 1-4 under Subjective:
VISIT 4/4 Review and Motivation
Since discharge or last visit, any all-cause re-hospitalizations or ED/UC:
{YES/NO/***:38137} Date: ***
Current symptoms:
SOB {DESC NONE OCCASIONAL DAILY CHANGE FROM BASELINE:2100022069}
Cough {Desc; cough:27341}
Wheeze {DESC NONE OCCASIONAL DAILY CHANGE FROM
BASELINE:2100022902}
Chest pain {desc; chest pain:17949}
Rx:
Inhaler names: ***
Oxygen therapy: {IFT OXYGEN:304010602}
PAP therapy: {YES/NO/***:38137}
Adherence: {Adherence:33815}
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Do you have a plan in the event that your breathing is worsening? {LG Breathing
Worse Plan:40349}
How did work go on your self-management activity from our prior visit? {LG Self
Management Activity :40352}
Negotiate a new plan or continue plan, or modify plan.
Motivational Questions
"How important is it for you to manage your COPD?" {NUMBERS; 1-10 (OUT OF
10):10902}
"Why it {IS/ IS NOT:23127} important?" ***
"How confident are you that you can help manage your COPD?" {NUMBERS; 1-10
(OUT OF 10):10902}
How would you change your confidence level ***
What seems most personally relevant to you of all we have discussed today and prior
visits: ***
Connects thoughts, behaviors and goals to values, strengths, and priorities
Review Visits 1, 2 and 3 risk stratification, emergency plan, self-management, GBT,
Risk Factors, Priority of Care, Barriers to Care, Goals of Care, Revise and/or add a new
goal
Please have MA ask the patient the following question after provider's Visit 4
completed prior to the the patient departing clinic: "Overall, how helpful was this
COPD program to help you understand your medical condition"? {Numbers; 15:17750} 1 is lowest score not helpful and 5 is highest score most helpful.
***
Review of Systems: (address pertinent)
@SOCHX@
@PMH@
@IMM@
@ALLERGY@
@CMEDNODISPNOREFILL@
Objective:
@VS@
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Visit ***/4 completed {LG Visit Mode:40357}
Physical Exam:
General appearance: {Exam, General Card:22982}
HEENT: {exam; heent:31974}
CARDIO: {heart exam:315510}
PULM: {Auscultation Lung:20254}
ABD: {Exam; abdomen brief:12273}
EXT: {Exam; extremity:5109}
NEURO: {exam; neuro physical:17800}
PSYCH: {psych exam:16943}
Diagnostics Review/Overview:
Spiro-confirmed obstruction {Yes/No/*:32965}
@RESUFAST(FEV1,FEV1PCT)@
Exacerbation(s): ***
Hospitalization(s): ***
COPD stage: {GOLD Stage categories for COPD (Optional):35758}
6 Minutes Walk Test: {YES/NO/***:38137}
Chest image (COPD or RV changes):
@LASTIMG(rad1039)@
@LASTIMG(RAD6027)@
Echo (RV TAPSE [or EKG R axis deviation] and LV EF)
@LASTECHO@
Labs:
AAT
@RESUFAST(A1APHENOTYPE,A1ATRYPSIN)@
ABG:
@RESUFAST(PH,PCO2ART,PO2ART,BICARBONATE,BASEEXCESS,PHADJ,O2SAT
ART,LACTATE,FIO2,SAMPLETYPE,DELSYS,ALLENTEST,BODYTEMPERAT)@
CBC:
@RESUFAST(WBC,HGB,HEMATOCRIT,EOSINOMAN,EOSINOABS)@
Smoking and/or environmental exposure {YES/NO/***:38137}
Vaccinations
@IMM@
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Oxygen therapy
Resting SPO2 on room air: *** %
Walking SPO2 without oxygen: *** %
Walking SPO2 with oxygen: *** % on *** LPM
Pulmonary Rehabilitation or routine home exercise: {YES/NO/***:38137}
Rx/Inhaler therapy: ***
INHALER
{INHALER EDU GIVEN BY:31486}
EDUCATION:
RE-DEMO:
{INHALER EDU PT
REDEMO:31487}
SPACER:
{SPACER GIVEN/NOT:31525}
(Pharmaceutical Assistance {YES/NO/***:38137})
PAP COMPLIANCE DATA DOWNLOAD
@FLOW(11,14,301070,2100001264,2100001271,2100001272,2100001273,210000126
1,2100001275,2100001276,2100001277,2100001278,2100001279,7070561,7070563,4
37,4376,4377,4378,4380,4382,4490,2100001268,2100001269,2100001267,4381,1284
5:LAST)@
Assessment/Plan:
@PROBAPNOTES@
@NAME@ has a COPD PEARL risk score {Desc; low/moderate/high:110033} for
readmission or death due to AECOPD: {LG Score Risk:40375}
{kar He She They:38442} has COPD, {Mild/Moderate/Severe:27396} with symptoms
{DESC; STABLE/IMPROVING/WORSENING:2100020620}
Summary of evaluation and differential or contributing factors to pulmonary care: ***
Emergency Action Plan discussed: {YES/NO/***:38137::"yes"}
Risk Factor/SDoH (from Visit 2) score is {Desc; low/moderate/high:110033}.
Barrier to care (from Visit 2): {Yes/no/NA/Results Pending:38513::"Results pending"}
Goals of Care (from Visit 3): {Yes/no/NA/Results Pending:38513::"Results pending"}
CODE STATUS: {Code Status:22922}
Patient-specific recommendations are the following:
Patient's self-management priority: ***
Diagnostic Tests Recommended: ***
Tobacco Counseling: Patient {WAS/WAS NOT:2100118327} counseled on the risks of
tobacco use. @CAPHE@ @TOBHXP@.
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Medication Reconciliation: {YES/NO/***:38137}
02 therapy: {increase/continue/decrease:33428}
• Current *** LPM
• Adherence: {Adherence:33815}
PAP therapy: {YES/NO/***:38137}
• Adherence: {Adherence:33815}
Inhalers: ***
Roflumilast if indication (severe COPD with AECOPD): {YES/NO/***:38137}
Vaccinations: {up to date:24347}
Exercise (Pulmonary Rehabilitation or PT): {Responses; yes/no/refused:28835}
Support/Referral: {Desc; advisable/necessary/not necessary:16725} for ***
Comorbidity Management/Previous referrals {LG Previous Referrals:40376} ***
Patient Education: {CRehab Learner Primary Learning Style:32047}; confirmed
{YES/NO/***:38137}
• Resource Live Well with COPD booklet and/or COPD Pocket Consultant Guide App
{YES/NO/***:38137}
• Patient and/or patient's family, {ACTIONS; HAVE/HAVE NOT:19434} received the
appropriate education on the treatment stated above, and have expressed
understanding and comprehension of the plan.
Orders:
@DIAGORDERS@
Patient-specific resource(s) needed:
{LG Risk Factors and Recommended Resource Allocation:40379}
@FOLLOWUP@
{LG Follow Up:40377}
In an effort to avoid potential COVID-19 exposure in this patient, this visit occurred by
telehealth. Verbal consent {STOP if was not:25643::was} obtained from patient, parent
or guardian to provide telehealth services after informed of risks, benefits and
alternatives.
Patient identification completed: {Yes/No:2::Yes}
Mode of Communication: {Blank:19197::"Telephone", "Video"}
{If Video specify application (Optional):37698}

120

Patient Location: {State Location:37697::Idaho}, {Blank:19197::"Home Residence"}
Provider Location: {Blank:19197::"Clinic"}
{Telehealth Time Coding (Optional):38424}
Consider E/M 99496 Visit 1 if TOC within 7 days and routine E/M Visit 2-4
AVS provided to patient and/or caregiver: {YES/NO/***:38137}
Route closed chart note to PCP/Care Team: {YES/NO/***:38137}
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Appendix I Appropriateness for Inclusion and Exclusion
Patient, @name@, is contacted at the recommendation of the hospitalist for screening and
discussion of participation in COPD quality improvement initiative. Interpreter present:
{INTERPRETER NEEDED:3040223}
Appropriate Criteria for Project
YES
Hospitalized during time frame of project
implementation
{.:1150429621}
Primary or secondary diagnosis of AECOPD
{.:1150429621}
Patient agreement to participate
{.:1150429621}
Discharge home
{.:1150429621}
Resides in county serviced
{.:1150429621}
Confirmed age 45 and older
{.:1150429621}
Obstruction on any prior Spirometry
{.:1150429621}

NO
Active Oncology treatment
{no default YES:28775}
Discharge to hospice, SNF, or LTC
{no default YES:28775}
Non-system PCP
{no default YES:28775}
Patient declines
{no default YES:28775}

Patient {DOES/DOES NOT:24725} qualify for COPD quality improvement initiative.
• Does not qualify - no further work with patient.
• Does qualify then proceed with PEARL
Letter to patient with discussion of the project. Questions were answered and{He She
They:38442} would like to participate in the initiative.
Based on PEARL, patient has {Desc; low/medium/high:30203} for readmission.
Recommendations are as follow:
• Low-risk patients are discharged to their PCP for follow-up or as planned by the hospitalist.
• Uncompleted risk stratification and moderate - high risk patients may be referred to
pulmonary clinic for COPD and transitional care management. Patient agrees to and
hospitalist authorized urgent referral generated to pulmonary clinic today for Dx COPD.
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Appendix J Participant Letter
You are receiving this letter asking you to voluntarily participate in a quality improvement
program. Xx, a Doctor of Nursing Student working with the Xxxx pulmonary specialty
group, will be leading this program in agreement between Xxxx and academic institution.
The goals of the program:
• Identify patients at increased risk of rehospitalization due to their diagnosis of Chronic
Obstructive Pulmonary Disease (COPD).
• Provide increased medical support and best practices for lung care through visits with a
specialty trained nurse practitioner working with a lung doctor and your primary care doctor
to determine patient engagement, risk factors, and barriers to care.
There are no financial obligations to participating. The project is not supported by a grant or
contract. There is no federal agency or department involved. The project is not funded by the
academic institution. The project receives in-kind donations related to the resources and
activities to fulfil the project.
Participants will include:
• Age 45 years and older, all incomes, genders, and residents of the defined metro area
• Admitted to the healthcare facility between the dates of June 1, 2021 and August 31, 2021
• The admission diagnosis must be primarily related to COPD
• The COPD must have been confirmed by breathing tests
• Discharged to home environment
• Participant will be excluded if they do not meet criteria or decline participation
Description of the project:
• Participants will not receive financial rewards
• The program does not place the participant at any known increase or unreasonable risk
• The participant may withdraw from the program at any time
• Participant data will be kept confidential, protected, secured, encrypted and de-identified
• XXXXXXXXX Hospitalist notifies the program lead of the participant interest to participate
and authorizes referral
• Prior to discharge from the hospital, the program lead or another provider will meet the
participant in the healthcare facility to describe the program, answer questions and confirm
willingness to participate in the program
• Once discharged, patient will be asked to participate in the following:
o Weekly visits with one of the providers listed below for a period of 1 month
o Visits are be completed in person at the first visit and then by video or phone visits as
the patient prefers
o Participant may be asked to have initial lab work and a heart ultrasound if indicated.
o Complete two surveys that will take approximately 5 minutes each
• Participant will be interviewed (30-60 minutes duration) as during a usual patient clinic
appointment
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•
•
•

Participant will continue to see their usual primary care provider and other specialists
Care will be communicated to care team
A final report will be provided to the healthcare facility and university for publication

Principal Faculty Advisor: Dr. Xx, Director of DNP in Leadership Program and Associate
Professor, School of Nursing Xxx
Quality Improvement Program Leader: Xx
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Appendix K Transitional Care Management and Primary Care Provider Letter
Scheduler starts after referral received.
Scheduler
@name@
• Interpreter: {ED SANE INTERPRETER USED:19851}
• Any prior Spiro/PFT ok
• Patient needs follow-up appointments scheduled simultaneously in 1 month:
o APP. If Home Health referral {no, yes:23860} ; If yes, then contact lead APP
to schedule.
o Within 7 calendar days of discharge, 1 hour (F2F preferred over Telehealth)
x1: {yes/no ***:36042::"Yes"};
§ if unable to schedule in 7 days then next available ie 14 days and
notify XX
o Weekly visits x3, 30 min (Telehealth option): {yes/no ***:36042::"Yes"}
o Appointment note: “COPD Pilot ***/4”
o Appointment made for Date *** with Provider ***
o Schedule with pulmonologist (if new to any pulmonologist 60 min or if
established then assigned pulmonologist in 2-3 months; if not available then
usual TE process): {yes/no ***:36042::"Yes"}
• Additional information needed and requested (example risk stratification pending or
patient requests): {Yes/No/*:32965}
• Patient also is also in a health partner program): {no, yes:23860}
• Send high priority to select MAs and lead APP
MA
@name@
Date of contact (within 48 business hours of discharge date but not same day excluding
holidays and Sa-Su): ***
• Document attempt X2 {YES/NO/***:38137}
Sources of information:
• Interpreter: {ED SANE INTERPRETER USED:19851}
• Source of information: {SOURCE:25620}
• Other sources of information: {Source; lab:60363}
Discharged from Location: ***
Discharge Date ***
Diagnosis/problem (as stated or listed 1st and 2nd from discharge note): ***
Medication changes at time of discharge and now home:
• Medication list updated: {YES/NO/***:38137}
Needs follow up on any hospital discharge orders pending or
lab/complete: {YES/NO/***:38137}
Additional information needed and requested from patient: {YES/NO/***:38137}

125

Appointment confirmed as highly complex visit:
• Date ***
• Provider ***
Send high priority to XXX and PCP (below)
Note to Provider @PCP@:
@name@ has agreed to participate in a quality improvement (QI) initiative to advance
evidence-based practice. This initiative is an agreement between XXX, a Doctor of
Nursing Student with a local academic university and the healthcare facility. The
program will be implemented between XXX.
Program Goal:
Reduce readmission with a diagnosis of COPD.
How: 1) apply risk stratification and 2) provide increased visits for 1 month by a
pulmonary specialty trained nurse practitioner to confirm best practice pulmonary care,
determine and communicate patient engagement, risk factors, and barriers to care to
improve value-based care and resource allocation.
The patient is asked to continue follow up appointments with their usual health care
provider(s) in addition to being a participant in the QI pilot program. Providers and care
team members associated with the participant will receive information about their care
during the time of the program. A final report will be provided to the university and
healthcare facility as well.
Please contact XXX, NP for further questions.
Thank you.
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Appendix L Outcome Measures
Outcome
1.

2.

3.

50% of COPD patients
referred to the pulmonary
clinic are seen within 714 days of discharge
(PO)
50% of COPD patients
referred to the pulmonary
clinic access 3 out of 4
outpatient pulmonary
clinic visits within 30
days s/p discharge (PO)
At least 1 pulmonary
provider(s), and staff (12 MA) in the healthcare
facility pulmonary clinic
receive training by the
project lead to use the
EHR COPD template by
the end of May 2021
(CO/PO)

Data Collection Instrument /

Analysis Goal

Data
Instrument:
• Data Collection Spreadsheet
Data:
• Re-created Data Collection Spreadsheet tracking:
o Timely access to care from time of discharge
o Number of pulmonary clinic visits completed/patient

Instrument:
• In-person meeting for training
• COPD template
• Data Collection Spreadsheet
• Forms
Data:
• Project lead created a COPD template to use for patient care
encounters, organized meeting to train staff on using
template:
• EHR COPD template created documenting evidence-based
care for guideline-based therapy (including education,
emergency action plan and hotline), risk stratification,
motivation, and barriers to care
o Data Collection Spreadsheet marked attendance of
trainees
o Provider: “How would you rate the ease for use of
the EHR patient care template” with comments
box (Product testing)

1. To quantify the ability of
the clinic to meet evidencebased clinic visit
recommendations

Analytic Technique
•
•

Retrospective chart
audit of EHR
Data Collection
Spreadsheet

2.

Tracked if appointments
completed at specified
times.

Quantitative
Descriptive statistic
“x % or n patients were
able to access the
pulmonary clinic
timely”

1.

Provider(s) and staff
attended training for use of
COPD template in EHR:
a) to reduce variation in
patient care
b) to complete project
aims and
c) to improve quality
outcome.

Retrospective review of
Data Collection
Spreadsheet
Dichotomous item
(Yes/No)
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Outcome
4.

80% of COPD patients in
the healthcare facility
pulmonary clinic have
risk stratification
documentation in the
EHR or data spreadsheet
by the 2nd pulmonary
clinic visit or between
June and by the end of
August 2021(CO).

Data Collection Instrument /
Data
Instrument:
• PEARL Risk Stratification Tool (Echevarria, 2017)
• Data Collection Spreadsheet
• Likert provider post-test question
•
Tool Data:
• Data from patient interview to complete PEARL Tool
housed in patient EHREHR and transferred to Data
Spreadsheet
• PEARL (Echevarria et al., 2017) used in context for
AECOPD for risk of readmission and/or death at 30 and 90days after discharge developed in two hospitals and
validated in a total of six hospitals (four external).
n = 2417 patients.
Five variables of PEARL:
• Prior admission (Patient descriptors, interviews, report from
index admission documented in chart/pulmonary clinic visit
note),
• eMRCD (dyspnea score with frailty component as patient
descriptor, interview, chart review),
• Age (patient descriptor, interview, chart review),
• Right ventricular function (procedure and laboratory results
of Echo RV TAPSE [or EKG R axis deviation], physical
exam positive edema),
• Left ventricular function (procedure and laboratory results
of Brain Naturetic Peptide [BNP], Echo LVEF, Physical
exam positive edema).
Each variable is weighted/scored with final scoring as
follows:
• PEARL 0-1 (low risk) = 20.7%.
• PEARL 2-4 (intermediate risk) = 42.1%.
• PEARL ≥5 (high risk) = 66.4%.
PEARL has the following research c-statistics:
Derivation 0.73
Internal Validity 0.68

Analysis Goal
Communicate patient risk
stratification for readmission or
death as: high, moderate, or low
risk using:
• PEARL as a context
specific research validated
tool (Echevarria, 2017)
Obtain provider satisfaction
measures

Analytic Technique
•
•

Retrospective chart
audit of EHR
Data Collection
Spreadsheet

Quantitative
Descriptive Statistics
Pie Chart
“x % or n patient
completed risk
stratification”
“x % or n were high
risk while x% or n were
moderate risk. Of the
moderate risk “x % or n
have additional risks for
trajectory toward high
risk”
“x% of providers
thought tool was
useful”
“x% rated ease for use
x”
Providers:
“x% of providers
reported satisfaction
with xyz”
Data report from
Microsoft Forms for
provider satisfaction
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Outcome

Data Collection Instrument /
Data
External Validity 0.70
The C-statistic can range from 0.50 to 1.00, with higher values
indicating better predictive models. A rough rule for
interpretation is that C-statistics above 0.80 indicate very good
models, between 0.70 and 0.80 good models, and between 0.50
and 0.70 weak models.
Presented at healthcare facility journal club to providers and
acute care leadership.

Analysis Goal

Analytic Technique

Provider Data:
• Likert Provider Satisfaction post-rating scale 0-10
o Provider: “How would you rate the ease for use of
this tool?” with comments box (Product testing)
5.

6.

80% of COPD patients in
the pulmonary clinic are
able to identify patientspecific motivation
impacting patient care as
documented in the EHR
by the 2nd pulmonary
clinic visit between June
and by the end of August
2021 (CO)

Instrument:
• Likert Motivation Scale of patient pre/post-test questions
• Data Collection Spreadsheet

80% of COPD patients in
the pulmonary clinic are
able to identify at least
one patient-specific risk
factor(s) including social
determinants for
AECOPD documented in
the EHR by the 2nd

Instrument:
• Multiple Choice Checklist, re-created Risk Factor Table
• Data Collection Spreadsheet

Data:
• Data from patient Interview housed in patient EHR
• The following are two patient motivation questions using a
standard motivational interviewing ruler 0-10:
1. Patient: “How important is it to you to manage your
COPD?”
2. Patient: “How confident are you that you can help
manage your COPD?”

Data:
• Multiple choice provides the following drop-down or
checklist menu and free-listing option for risk factors
(Deniger et al., 2015), housed in patient EHR:

Communicate readiness or
motivation measured from
patient interviews to provide
insight into patient’s
perceptions about how they feel
about change.
Identify patients who are
willing or persuaded to improve
their health versus patients not
willing to change to facilitate
goals of care, budgets for
resource allocation or
anticipated readmissions and
policy decision-making

•

Communicating risk factors
unique and specific to every
patient are important to identify
during patient interviews to
support patient-specific needs

•

•

Retrospective chart
audit of EHR
Data Collection
Spreadsheet

Quantitative
Descriptive statistic Bar
Graph
“x % or n patient had x
motivation to impact
their care with x%
confident in their ability
to manage care and x%
willing to help”

•

Retrospective chart
audit of EHR
Data Collection
Spreadsheet

Quantitative
(Descriptive statistics,
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Data Collection Instrument /

Outcome
pulmonary clinic visit
between June and by the
end of August 2021 (CO)

o
o
o
o
o
o
o
o
o
o
o
o

Data
Demographics (age, place of residence, access)
Ethnicity
Physical Characteristics (2+ falls or frailty by
PEARL)
Lifestyle Behaviors (smoking, alcohol, noncompliance)
Socioeconomics (Medicare/caid, no home
ownership)
Hospitalizations (any prior, <2>4 days in hospital)
Comorbidity (3+)
Diagnostics (HF, COPD, Pneumonia)
Medications (high risk or 5+)
Primary Care (none)
Follow up (none)
Monitoring (available at home or not)

Analysis Goal

Analytic Technique
pie chart) and
Qualitative data
(themes, “Risk factor x
was a contributing
factor to AECOPD x %
of the time”)
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Outcome
7.

80% of COPD patients in
the healthcare facility
pulmonary clinic can
identify at least 1 patientspecific perceived
barrier(s) impacting
patient care documented
in the EHR by the 2nd
visit between June and
by the end of August
2021 as measured by
EHR audit or data
spreadsheet tool (CO)

Data Collection Instrument /
Data
Instrument:
• Multiple Choice Checklist, re-created by project lead
• Data Collection Spreadsheet
Data:
• Multiple choice provides the following drop-down or
checklist menu and free-listing option for barriers to care
housed in patient EHR:
o Personal and Biologic
o Household and Social
o Healthcare System and Economics
o Environmental
o Other

Analysis Goal
Communicate the patient’s
perceived or real barriers to
care

Analytic Technique
•
•

Retrospective chart
audit of EHR
Data Collection
Spreadsheet

Qualitative
Develop categorical
patterns
“x % or n patient were
able to identify at least
1 barrier to care”
“x was the most
frequently cited barrier
to care” or “the top two
cited barriers to care
were…” or
“the patterns identified
as barriers to care were
xyz”
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Outcome
8.

9.

80% of COPD patients in
the healthcare facility
pulmonary clinic report
their care experience by
the end of August 2021
(CO)

80% of COPD patients in
the healthcare facility
pulmonary clinic have
their care plan
communicated to the
PCP and/or care team
between June and by the
end of August 2021
(CO/PO)
10. Document of project
outcomes: readmission
rate, risk stratification,
resource and support
services needed for
value-based care
communicated to
Stakeholders by the end
of May 2022 (PO)

Data Collection Instrument /
Data
Instrument:
• Likert Scale Patient Experience post-test questions.
Data:
• One patient measure from interview using post-rating 1-5:
1. Patient: “Overall, how helpful was this project to your
understanding of your medical condition?”
(Course/Project evaluation or Post-Visit Patient
Satisfaction)

Instrument:
• Data Collection Spreadsheet
Data:
• EHR patient encounter COPD template

Instrument:
• Document created by project lead
Data:
• Readmission Rate
• Readmission Risk Factors
• Patient Motivation
• Barriers to Care
• Resources Needed

Analysis Goal
“…good patient experience is
associated
with important clinical
processes and outcomes.
... Patients with
better care experiences often
have better health outcomes”
(https://www.ahrq.gov/cahps/)

Communication and
coordination of timely patient
care needs with the team is
critical. Call or forward
completed EHR COPD
template note to the PCP and/or
care team at the time of the
patient care visit.
Communication to
stakeholders/decision-makers
will facilitate policy and
budgets for real impact on
patient-specific factors at
completion of the pilot project

Analytic Technique
Post-evaluation from
interview question
using Likert scale
Quantitative
Descriptive statistic
“x % of patients
reported x experience
participating in the pilot
project, x %
recommend this project
be continued for other
patients, x% thought
this project
communicated their
needs”
•

Retrospective chart
audit of EHR
• Data Collection
Spreadsheet
Dichotomous item
(Yes/No)

•
•

Retrospective chart
audit of EHR
Data Collection
Spreadsheet

Document on outcomes
and recommendations
Dichotomous item
(Yes/No)

Report with
recommendations to
stakeholders

Communication to PCP

Patient Care Experience
(post-project, Likert)

Provider Satisfaction for
PEARL (post-project,
Likert)

30-day readmission,
# days between admit,
Index Dx, Discharge Dx,
LOS

Visit 4 (30 min,
telehealth with provider)

Visit 3 (30 min,
telehealth with provider)

Visit 2 (30 min,
telehealth with provider)

Visit 1 (60 min, home or
F2F, other, with
provider)

Clinic follow up by
clinical staff (timeframe
2 days by telephone or
mychart)

Barriers listed

Motivation score (pretest/post-test, Likert
EHR)

Risk factors/SDoH
table

Risk stratification tool
(PEARL)

Discharge disposition
(location)

Index diagnosis

Provider and staff
training EHR

COPD template
(included emergency
action plan and GBT
(GOLD)

Gender

Year of birth

De-identifier key

132

Appendix M Data Collection Spreadsheet

1
2
3
4
5
6
7
8
9
10
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Appendix N CITI Training Certificate
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Appendix O Internal Review Board Letter of Determination
Re: IRB Determination: Risk Stratification to Improve Value-Based Care: A COPD Pilot Project
in a Pulmonary Specialty Clinic
Dear Xxxxxxxxx,
I appreciate your request for IRB determination regarding protection of the rights and welfare of
subjects involved in the above referenced project.
The purpose of this DNP project is to implement a pilot program for patients hospitalized with
COPD,
to include risk stratification in order to expedite transitional care from hospital discharge to
access of
an outpatient pulmonary specialty clinic.
Intended project outcomes include:
• Improve identification of patients with moderate to high risk for COPD readmission
• Improve communication of patient-specific risks, motivations, and barriers to care
• Improve communication for resource allocation specific to higher risk patient needs
While the project is a systematic investigation, it is not designed to develop or contribute to
generalizable knowledge. Patients will not be randomized to different interventions. The project
does
not entail greater risk to individuals than would normally be anticipated under the standard-ofcare.
The project does not meet criteria for human subjects research but rather is evidence-based
quality
improvement (QI). The project does not need to be reviewed by XXXXXXXXX Research or the
SLHS
IRB. For any extramural presentations where results of this QI project are revealed, it is required
to
avoid any use of the word research in a poster, any other representation of the project or in its
verbal
description.
Additional Notes:
1. This determination could be affected by substantive changes in the project design, subject
populations, or identifiability of data. If the project changes in any substantive way, please
contact our
office for clarification.
2. Please note that federal regulators have made it clear that any publication describing a project
as
research must have prior IRB review and approval. Therefore, projects determined to be
Evidence
Mailing Address: Street Address:
Institutional Review Board Institutional Review Board
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Appendix P Timeline
Project: Operationalizing Risk Stratification in a Pulmonary Specialty Clinic to Improve Outcomes in Adult Patients with COPD
Month/Year
Jun
Jul
Aug Sep/ Oct
Nov Dec Jan/ Feb Mar Apr May Jun
Sep Oct
Nov
Dec Jan
PHASES
20
2021
Jul
Feb
20

PLANNING
Literature review and synthesis of evidence
Theoretical model selected
Timeline and logic model outcome
measures
Risk management for SWOT
Scholarly project proposal submitted
Develop project scope
Define milestones
IT development: Risk stratification tool,
COPD care plan
Faculty, Stakeholder, Champion -team
meetings
Plan for data analysis and collection
Plan for evaluation and measurement tools
Budget and resource procurement
Software selection
IRB review and QI determination
Plan for dissemination
Plan for reporting
My Clinical Exchange
Training sessions
Hospital discharge planning - team meetings
Clinic staff - team meetings
Policy analysis

Aug

Mar
2022

Apr
May
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Project: Operationalizing Risk Stratification in a Pulmonary Specialty Clinic to Improve Outcomes in Adult Patients with COPD
Month/Year
Jun
Jul
Aug Sep/ Oct
Nov Dec Jan/ Feb Mar Apr May Jun
Sep Oct
Nov
Dec Jan
PHASES
20
2021
Jul
Feb
20

IMPLEMENTATION
Patient pulmonary clinic visits (F2F,
Telehealth, Domicile)
Patient calls
Communication regularly – team meetings
DATA COLLECTION
Data points defined
Collect data
Monitor and manage unforeseen changes
Update stakeholders
DATA ANALYSIS
Evaluation of measures
Data analysis and interpretation
Update stakeholders
DISSEMINATION
Evaluation of project
Scholarworks
Presentation of results
FINAL REPORT (Academia and
Healthcare Facility)
Project completion with academics (optional
extensions/expansions with healthcare
facility)
Scholarly project presentation and
manuscript (Academia and Health System)
Commencement

Aug

Mar
2022

Apr
May
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Appendix Q Resource Allocation
Risk Factor

Resource

Risk Factor

Community apps
and programs list
Support groups

Drugs (Illicit)

Counselor

Alcohol

Counselor

Lifestyle
Medicine,
Nutritionist,
Health coach
Primary Care
Provider

Exercise none

Pulmonary
Rehab, PT,
YMCA, Gym

ABG (hypoxia or hypercapnia)

Unemployment

Social Worker

Medication Non-adherence

02 therapy,
BiPAP,
DME
Health coach,
Pharmacy

Income level (low, does not own
home)
Insurance (none or Public)

Social Worker

Respiratory Medications
(uncovered or poor technique)
Home Monitoring Absent
Digital Gap

Pulmonary Provider (none)

Pulmonologist
Referral
Primary Care
Provider Referral

FEV1/FVC <50

Palliative Care,
Attorney

Education level low

Age >75-80
Gender
BMI (<24 or >35)

Follow up not scheduled

PCP (none)

Advance Directives

Yes/No

SW, SHIBA, Rx
assistance

Smoking

Yes/No

Resource

Pharmacist, RT
Telehealth,
RPM,
Pharmacy,
Insurance,
Technologist
Pulmonologist
Tobacco
Cessation,
Health coach,
Counseling
Match learning,
Health coach
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Appendix R Expense Report (Year 1)
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Appendix S Year 2-3 Budget Report
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Appendix T Statement of Operations Report

